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This study examines the transformation of BHK-21 cells to an-
chorage independence by BKV. It follows an observation made in this 
laboratory that a clone (L29) of BKV transformed BHK-21 cells appeared 
nuclear large T antigen negative by IFA and immunoperoxidase assays yet 
was capable of virus rescue (80). This observation stimulated many 
questions as considerable evidence indicated that the closely related 
SV40 large T protein is necessary for viral DNA replication, and trans-
formation initiation and maintenance. The current study was undertaken 
to examine the L29 clone and other clones of anchorage independent BKV 
transformed BHK-21 cells first for the presence of the BKV large and/or 
small T proteins as detected by immunoprecipitation of 35s-methionine 
labeled proteins, then for the parameters which may influence or be 
influenced by the expression of these viral proteins. 
CHAPTER I I 
LITERATURE REVIEW 
The papovaviruses conasitute a group of viruses drawn together 
by similar physical characteristics. Their unenveloped capsid struc-
ture is icosahedral in shape and 40-55 nm in diameter. Their genome is 
composed of double stranded DNA in a circular, covalently closed, super-
coiled conformation. The size of the genome is relatively small, rang-
ing from 3 X 106 daltons to 5.5 X 106 daltons. This small size has made 
the papovaviruses popular subjects in the study of eukaryotic gene ex-
pression and regulation. They are also one of the most widely studied 
groups of viruses for both their in vitro and in vivo oncogenic poten-
tial . 
The papovaviruses can be divided into two genera. These are the 
papilloma viruses and the polyoma viruses. The papilloma virus group 
includes a number of different isolates of viruses capable of causing 
warts in humans and animals. They are separate from the polyoma viruses 
for two reasons. The first is that the papilloma virion capsid is 55 nm 
in diameter compar~d with a 40-50 nm diameter capsid of polyoma viruses. 
The second is that papilloma viruses cannot successfully be grown in 
tissue culture while most polyoma viruses can be. 
The first DNA tumor virus to be isolated and characterized was 
a papilloma virus described by Shope in 1933 (104), who studied warts 
which occasionally became malignant in wild cottontail rabbits. He no-
ticed that cell free extracts made from warts, after passage through 
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bacteria retaining filters, were capable of causing new warts in rabbits 
at the inoculation site. Rous (91) reported on the transformation of 
the cottontail rabbit papilloma wart to a squamous cell carcinoma. Sub-
sequent bovine papilloma isolates were found to be capable of transfor-
mation of bovine and murine cells and human isolates were found to be 
capable of transformation of human cells(5,79). 
In most DNA and RNA tumor viruses transformation is accompanied 
by integration of the viral sequences which are required for transfor-
mation maintenance. Among the papovaviruses, papilloma viruses are u-
nique in that integration of viral sequences in tumor cells or in~ 
vitro transformed cells appears to be lacking (2,61,65). The virus ex-
ists in these cells as an episome in high copy number. It therefore 
has afforded investigators a unique cloning vector for the study of eu-
karyotic gene expression. The mechanisms of transformation by this 
group of viruses are unknown. 
The polyoma genus of papovaviruses consists of viruses of pri-
mate and rodent origin. The virus of rodent origin is polyoma virus. 
Originally, it was detected as a contaminant in cell free extracts of 
tissues from AK mice being used for studies on murine leukemia (47). 
The virus was first grown~ vitro in mouse embryo cells and the cyto-
pathic effect and productive infection was described by Stewart and 
Eddy (27,113,114). The virus was found to be capable of inducing mul-
tiple types of tumors in hamsters and mice (114,115), thus the name 
polyoma. It was also found to be capable of transformation of mouse and 
hamster cells in culture (21 ,133). 
The primate polyoma viruses include the simian virus SV40 and 
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the human viruses JC (JCV) and BK (BKV). SV40 was originally isolated 
by Sweet and Hilleman (120) from cultures of rhesus monkey kidney cells 
which were similar to those being used to produce poliomyelitis vac-
cines. Eddy et al. (26) first showed that SV40 was oncogenic in new-
born hamsters and Shein and Enders (103) first reported the transforma-
tion of cultured cells by this virus. In addition to human cells SV40 
is also capable of in vitro transformation of mouse, rat and hamster 
cells (6,103) 
The human papovaviruses JCV and BKV were both isolated in 1971. 
JCV was isolated from brain tissue of a patient with progressive multi-
focal leukoencephalopathy (PML) (82). The repeated isolation of JCV 
particles from PML brain tissue makes it the papovavirus most closely 
associated with human disease. Papovavirus like particles in PML brain 
tissue had been identified earlier from electron micrographs but Padgett 
et al. (82), utilizing primary human fetal glial cells, were the first 
to grow the virus in culture. JCV is highly oncogenic in newborn ham-
sters when inoculated intracerebrally (134) and is capable of causing 
cerebral neoplasms when injected into the brains of owl monkeys (67). 
JCV and JCV DNA can transform primary hamster brain cells in culture 
(34). 
BKV was isolated from the urine of a renal transplant patient 
by Gardner (36). They observed polyoma-like virus particles by electron 
microscopic examination of urine sediment from an immunosuppressed kid-
ney transplant patient. They were then able to cultivate the virus in 
African green monkey kidney cells and determine that it was a newly de-
scribed virus of the papovavirus group. Several observations estab-
lished BKV as a human virus. BKV was isolated exclusively in humans, 
it grew preferentially in human cells and antibodies to BKV were de-
tected in 70% of several populations (11,101,122). 
In 1973 this human virus was found to be capable of transform-
ing (hamster) cells in culture (69). Subsequently it was shown that 
BKV can stably transform rat (132), mouse (87), rabbit (87) and monkey 
(10,87) cells and abortively transform human cells (87). BKV DNA or 
DNA fragments can also transform cells in culture (86,121). 
In some cases cells transformed by BKV ~vitro are oncogenic 
in vivo. Most hamster cells transformed by BKV ~vitro induce subcu-
taneous tumors after injection into weanling hamsters (24). However, 
mouse and rabbit cells which were transformed by BKV in vitro did not 
produce tumors in the homologous host (87). 
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BKV is oncogenic when injected directly into hamsters. Studies 
have shown that it is weakly oncogenic when injected subcutaneously in-
to newborn hamsters (77) and strongly oncogenic when injected intrave-
nously or intracerebrally (18). The in vivo tumor production is an ob-
vious way of determining oncogenic potential and selecting transformed 
cells. For the in vitro study of transformation certain characteristics 
of transformed cells must be considered for their selection and study. 
When cells are infected by papovaviruses one of three things 
may occur, depending on the species of infected cell and/or the state 
of the infecting genome. If the cell is permissive the complete viral 
genome will be replicated, infectious virus will be produced and the 
cell will be lysed. If the cell type is semi-permissive only a few 
cells will become lytically infected and virus in the culture will be 
produced at a slow rate such that the cell culture survives. If the 
cell type is non-permissive for the virus transformation may result. 
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Cells transformed by papovaviruses can exhibit a number of 
properties which distinguish them from normal cells. Some of these 
properties may be utilized as a means of selecting transformants. One 
of these properties is that transformed cells lack normal contact inhi-
bition and thus have a high or indefinite saturation density. Trans-
formed cells loose their dependence on anchorage and can grow in agar 
suspension. Another property that transformed cells exhibit is tumor 
formation upon injection into susceptible animals. However, this prop-
erty is not absolute as some continuous cell lines such as 3T3 cells and 
BHK-21 cells, can not only grow indefinitely in culture but can also be 
tumorigenic under certain circumstances (8,117). Transformed cells also 
usually have a reduced requirement for growth factors present in serum. 
Thus, they can continue dividing in low serum concentrations which 
would limit the growth of non-transformed cells. Generally, transformed 
cells grow in a less ordered manner where they pile up on each other 
instead of maintaining an almost geometric, even monolayer. 
Transformed cells also may exhibit certain characteristic sur-
face and intracellular changes. One of these is increased agglutina-
bility by lectins which was described by Burger and Goldberg (13) and 
another is increased rate of nutrient transport. Another characteris-
tic cell surface change that accompanies transformation is the appear-
ance of virus specific transplantation antigen (TSTA). This was first 
indicated by the fact that animars immunized with SV40 or polyoma were 
resistant to subsequent challenges by transplantable tumors induced 
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by the respective virus (49,57). Intracellularly, transformation may 
be accompanied by a disruption of the cytoskeleto~ in particular the 
disruption of the actin cables. This disruption of the organization of 
actin cables may be the direct cause of other phenotypic changes seen in 
transformation. 
One method of determining the presence of viral DNA in trans-
formed cells is by the rescue of the transforming genome from the cells. 
Although the transforming genome or parts of it becomes covalently in-
tegrated into the cell's chromosome, under certain circumstances it can 
be rescued as a freely replicating genome. Gerber and Kirchstein (39) 
reported that when SV40 transformed cells were co-cultivated with per-
missive cells SV40 could be detected in the culture. If the two cell 
types were artificially fused with inactivated Sendai virus, infectious 
SV40 appeared in the culture fluid earlier and in much higher titers 
(38). Cells could also be successfully fused and virus rescued using 
polyethylene-dimethylsulfoxide (78) instead of inactivated Sendai virus. 
The mechanism of virus rescue from transformed cells is not 
clearly understood. Results suggest that rescue depends on a diffusable 
factor supplied by the cytoplasm of the permissive cell rather than on 
the transfer of viral DNA from the transformed cell nucleus to the per-
missive cell nucleus. Weaver et al. (135) fused SV40 transformed ham-
stercells with African green monkey kidney (CV-1) cells and then sepa-
rated the two types of nuclei in a sucrose gradient. They then deter-
mined the presence of infectious virus in the nuclei from different 
fractions by an infectious center assay. They found that infectious 
virus first appeared in the transformed cell nucleus and later was pre-
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sent in both types of nuclei. Croce and Kaprowski (20) and Poste et al. 
(88) fused SV40 transformed cells with enucleated permissive cells and 
obtained infectious SV40. 
Other evidence of virus in cells transformed by papovaviruses 
includes the demonstration of virus specific antigenic proteins, or vi-
ral messenger RNA (mRNA). Evidence for virus also includes the detec-
tion of virus specific DNA sequences. 
Assays for transformation employ the phenotypic changes of 
transformation as a basis for selection. One such method developed by 
Stoker and MacPherson (118), involves exposing sub-confluent cultures of 
cells to virus and then plating them at low cell densities. The un-
transformed and the transformed cells both form colonies that can be 
distinguished by their characteristic density and morphology. Another 
assay involves exposing monolayers of cells to virus and after 2-3 weeks 
harvesting the transformed cells which appear as dense foci of cells 
growing out from the monolayer of untransformed cells. In another assay 
(109) cells are infected with virus and plated at low densities in me-
dium containing low concentrations of serum, insufficient to support the 
growth of untransformed cells. Cells that are stably transformed are 
able to divide continuously in very low concentrations of serum. The 
method of selection that most closely correlates with ~vivo tumorigen-
icity is the selection of transformants in soft (0.33%) agar suspension 
(68). In this method semi-confluent cultures of cells are harvested 
and infected with virus. The cells are then plated in 0.33% agar on a 
0.9% agar cushion. The transformed cells form large colonies in 2-4 
weeks. Transformed cells selected for by growth in soft agar most 
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closely correlate with~ vivo tumorigenic potential. 
Of the well studied papovaviruses (SV40, BKV, Polyoma) produc-
tive infection begins with the adsorption and penetration of the cell 
by the virus, then proceeds to uncoating of the nucleic acid in the nu-
cleus or cytoplasm. The lytic cycle can be divided into two phases 
separated by bidirectional replication. These phases are called early 
and late. These phases correspond to the half of the genome that is 
transcribed before DNA replication and the half that is transcribed on-
ly after DNA replication. The early region codes for non-structural 
proteins that are involved in transforming infections and in viral DNA 
replication. The late region codes for structural proteins which com-
pose the capsid structure. Mature virions are assembled in the nucleus 
and released when the cell lyses. 
Of the primate papovaviruses SV40 is the most widely studied. 
For reference purposes the genome is divided into map units with the 
single restriction endonuclease Eco Rl cleavage site designated as 0 
map units. The early mRNA sediments at 19S in neutral sucrose gradi-
ents. It is transcribed from one DNA strand mapping from 0.658 units 
to 0.153 units. Early studies indicated that there was a single 19S 
species of mRNA that coded for the early protein. This protein was 
called the large T protein, molecular weight 90,000-100,000 daltons. 
Subsequent studies, including~ vitro translation of the 19S species 
of mRNA (83) found that the existence of a single early mRNA was incon-
sistent with the characterization of proteins found. An additional 
protein of molecular weight 17,000-22,000 daltons, the small t protein 
was also coded from this l9S class of mRNA. The question that this 
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finding posed was how a region of DNA with the capacity to code for a 
100,000 dalton protein could also code for a 20,000 dalton protein. 
This question was answered when two distinct mRNAs, each of which were 
approximately the size of the entire early region were identified. 
Berk and Sharp (4) first mapped the mRNAs and determined that they could 
be distinguished by sequences that were spliced out. They did this by 
treating hybrids between cytoplasmic mRNA and labeled viral DNA with 
single strand specific Sl nuclease. They then analyzed the protected 
·DNA products on neutral and alkaline gels. The larger mRNA was 2,500 
nucleotides and coded from DNA mapping from 0.67 to 0.54 and from 0.54 
to 0.14. The smaller mRNA was 2,200 nucleotides long and was coded 
from DNA mapping from 0.67 to 0.60 and from 0.54 to 0.14. Included in 
the spliced out region from the smaller mRNA was a translation termina-
tion codon. The smaller mRNA coded for large T protein and the larger 
mRNA coded for small t protein (109). 
After the onset of DNA replication the pattern of mRNA synthesis 
changes. In addition to early region transcription the late region is 
also transcribed. There are at least two species of late mRNA, one l6S 
species coding for viral capsid protein 1 (VPl) and one 19S mRNA coding 
for VP2 and VP3. VP2 and VP3 are translated from different reading 
frames of the l9S mRNA. Recently, there was an additional late region 
protein identified (54). This is the 7,900 dalton agnogene product 
coded from the only open reading frame in the late region. The protein 
is a DNA binding protein and may prove to have a role in virus assembly. 
The organization of the genome of BKV is very similar to that 
of SV40. Yang and Wu (137,138), by direct sequence analysis showed o-
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ver 80% sequence homology between late regions and over 70% homology in 
the early region of the two viruses. This extensive homology was also 
demonstrated by Seif et al. (99). The early region of BKV, like that 
of SV40 codes for two proteins, T and t. This region extends from .67-
.16 map units and the late region extends from 0.93-0.14 map units. 
Manaker et al. (70) examined the early and late mRNAs of BKV by the Sl 
technique of Berk and Sharp (4). They found that the mRNA coding for 
large T extends from 0.66-0.16 map units with a spliced out region from 
0.59-0.53 map units. The late region of BKV also codes for 3 structural 
proteins VPl, VP2, and VP3. The map positions of the major RNA segments 
in the late BKV genomic region were also found to be analogous to those 
of SV40. There is also an agnogene open reading frame in the late re-
gion of BKV but the gene product has not yet been identified. 
The genome organization of the early region of the murine papo-
vavirus polyoma as well as functional properties of early proteins are 
substantially different from those of BKV and SV40. The single Eco Rl 
cleavage point is still designated 0 map units and the circumference 
is 100 units. The region from map unit 75 clockwise to map unit 37 con-
tains the information for the early mRNAs. Unlike SV40 and BKV there 
are 3 known early mRNAs coding for 3 known tumor proteins (110). One 
RNA extends from map unit 75-25 with 48 bases spliced out at map unit 
87. The messenger is translated through to the stop codon at 89 map 
units and gives rise to small t protein, molecular weight 22,000 dal-
tons. Another messenger extends from map units 75-28 with 61 bases 
spliced out at map unit 87. The splice removes the small t stop codon 
and the message is translated through to map unit 99, giving rise to 
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middle T protein, molecular weight 55,000 daltons. The third messenger 
extends from 75-27 map units and has a region of 385 bases spliced out 
from map units 80-87. The stop codons at map positions 87 and 99 are 
bypassed in a different reading frame and the message is translated 
through to map position 27 giving rise to large T protein, molecular 
weight 100,000 daltons. 
The reports of the molecular weights of the BKV tumor proteins 
have been few and somewhat varied. Using the method of immunoprecipi-
tation from labeled cell extracts with anti-tumor serum followed by so-
dium dodecyl sulfate (SDS) gel electrophoresis and autoradiography 
Farrell et al. (31) immunoprecipitated a protein of 86,000 daltons from 
both BKV infected monkey kidney cells and BKV transformed hamster cells. 
Rundell et al. (96) isolated from BKV infected human embryonic kidney 
(HEK) cells a 32 P labeled protein that on SDS gels was indistinguisha-
ble from the SV40 large T protein. From BKV infected HEK cells Simmons 
et al. (107) isolated 35s-methionine labeled proteins with molecular 
weights 97,000 daltons and 94,000 daltons. By immunoprecipitation with 
anti-tumor serum from BKV infected HEK cells Simmons et al. (105) iso-
lated a 17,000 dalton protein which they identified as the BKV small t 
protein. Olive et al. (81) precipitated a 22,000 dalton protein from 
BKV transformed BHK-21 cells which may be the BKV small t protein. 
Of the primate papovaviruses the SV40 tumor proteins are the 
most widely studied. The large T protein can be detected in the nucleus 
of lytically infected and transformed cells by indirect immunofluores-
cence with anti-tumor serum and can be immunoprecipitated with anti-
tumor serum. Large T protein has also been detected on the surface of 
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infected cells by lactoperoxidase-catalyzed radioiodination of surface 
proteins (112), by immunoprecipitation of large T antigen from purified 
plasma membranes obtained from SV40 transformed cells (111) and by im-
munofluorescence using antiserum prepared against purified large T pro-
tein to stain the surface of cells (111). 
Functional aspects have also been widely studied. Studies with 
temperature sensitive (ts) mutants have shown the SV40 T protein to be 
essential for transformation by this virus. Stimulation of cellular 
DNA synthesis, transformation initiation and maintenance and initiation 
of viral DNA replication have all been attributed to the large T protein 
(12,41 ,59,124). 
Rundell et al. (94) with the use of a constructed deletion mu-
tant lacking part of the SV40 A gene from the early region were able to 
show that the T protein is a product of the A gene. Previous to that 
Tegtmeyer (125) found that ts mutants in the A gene failed to initiate 
stable transformation of cells at the restrictive temperature. After 
establishment of transformation at the permissive temperature some cell 
types reverted to a normal phenotype at the restrictive temperature. 
Martinet al. (72) studied the ability of ts mutants of SV40 to trans-
form Chinese hamster lung cells. They found that only mutants in the A 
region failed to transform at the restrictive temperature when subcon-
fluent Chinese hamster lung cell monolayers were used. Transformed cell 
lines then lost the transformed phenotype at the restrictive tempera-
ture. In addition, Brugge and Butel (12) studied the A gene function in 
the maintenance of SV40 transformation in mouse, hamster and human 
cells. Cells transformed by the tsA mutants exhibited the phenotype 
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of transformed cells at the non-restrictive temperature. However, when 
they were grown at the restrictive temperature they were similar to nor-
mal untransformed cells. These early studies established the link of 
the A gene and A gene product to the transformed phenotype. 
SV40 large T antigen also has a stimulatory effect on DNA syn-
thesis. Tjian et al. (127) isolated SV40 large T protein and microin-
jected it into the cytoplasm of cultured cells. They found that the T 
protein rapidly accumulated in the nucleus and that it stimulated DNA 
synthesis in quiescent cells. Kriegler et al. (59) loaded red cell 
ghosts with purified large T protein and fused them with cells infected 
with the SV40 tsA mutant defective in viral DNA synthesis. They found 
that by~ situ hybridization that the microinjection of purified large 
T protein resulted in an increase in the amount of viral DNA sequences 
in the monolayer. Finally, Mueller et al. (76) microinjected different 
early viral DNA fragments and studied the effects. They found that as 
little as 70% of the early region including sequences coding for the 
amino terminal end was required for stimulation of cellular DNA syn-
thesis. 
Lanford and Butel (64) utilized an SV40-adenovirus hybrid (PARA) 
mutant which induced the synthesis of SV40 large T antigen that is not 
transported to the nucleus, but accumulates in the cytoplasm. Cells 
transformed by this mutant (PARA cT) exhibited decreased colony forming 
ability in suspension both in 10% and 1% serum as compared to cells 
transformed by the wild type hybrid. Both grew to high saturation den-
sities in 10% serum. In 2% serum the saturation density of the wild 
type hybrid was not altered but that of the mutant was 3 to 5 fold low-
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er. In 2% serum the wild type transformants increased in cell number 
more rapidly than the PARA-ct mutant transformants. The mutant .trans-
formants were also less tumorigenic than wild type transformants. 
Studies on the small t protein function in SV40 infections have 
been made utilizing mutants deleted in the genome region unique to small 
t protein. This is the region between 0.54-0.59 map units which is a 
coding sequence for small t protein and an intervening sequence for 
large T protein (84). Deletion mutants within the region produce trun-
cated forms of small t protein. Bouck et al. (9) transformed rat cells 
and Chinese hamster lung cells with the 0.54-0.59 deletion mutant and 
selected the transformants in soft agar. Using this method of transfor-
mation selection they found that 0.54-0.59 mutants were only 1-2% as 
efficient in transformation as the wild type parent. Another difference 
between the 0.54-0.59 mutant transformed cells and wild type fully 
transformed cells is that cells transformed by the mutant fail to loose 
their organized actin cable network (42). In studies of oncogenicity 
investigators found that the 0.54-0.59 mutant required a longer latent 
period for tumor induction in hamsters than did the wild type virus 
(22). This study did report suggestive evidence that tumors induced in 
hamsters by the 0.54-0.59 deletion mutant tended to metastasize where-
as tumors induced by wild type SV40 rarely did so. In this study 30 
hamsters were injected with wild type virus. All 30 developed tumors 
and none metastasized. Fifteen hamsters were injected with mutant vi-
rus. Thirteen hamsters developed tumors of which 6 metastasized. 
Metastatic potential is a characteristic that is not usually associated 
with papovavirus oncogenesis. From these studies it is obvious that the 
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small t protein contributes to the transformed phenotype. 
Further studies demonstrate that the state of the cell prior to 
and during transformation, in addition to the expression of viral pro-
teins influence the outcome of infectiono For the contribution of small 
t to transformation this was demonstrated in studies by Martinet al. 
(71). They studied the same 0.54-0.59 mutant as Bouck et al. (9) and 
found that it could transform actively growing Chinese hamster lung 
cells nearly as efficiently as wild type virus. However, when these 
cells were not actively growing at the time of infection the transfor-
mation frequency relative to wild type dropped 50 fold. 
In regards to the state of the host cell and the contribution 
of large T to transformation it was discovered that both SV40 and poly-
oma could generate two types of transformed rat or hamster cells depend-
ing on the method of selection of the cells. The transformants selected 
for by growth in agar were designated A transformants and those selected 
for by focus formation were designated N transformants (98). When tsA 
mutants of SV40 and polyoma were used for transformation they found that 
A transformants were able to maintain the transformed phenotype at the 
restrictive temperature while theN transformants could not (37,90,98, 
100). From these studies it appeared that transformation was totally 
under control of the A gene inN transformants. In the A transformants 
however, an additional factor from the host or virus was utilized to 
maintain the transformed phenotype at the restrictive temperature. In 
these studies the A transformants were those cells in a resting state 
(agar selection) at the time of exposure to virus and for the 4 or 5 
days immediately following. The N transformants were those actively 
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growing (focus formation selection} at the time of exposure to virus. 
More recently it was determined that in rat cells A transformants tend 
to be produced by exposure to virus at high multiplicities of infection 
and N transformants are found after exposure to virus at low multipli-
cities of infection (89}. In these rat cells the A transformants have 
multiple copies of integrated SV40 and the N transformants have a single 
integrated copy (16}. Thus, at least in rat cells gene dosage may be 
responsible for the relation of multiplicity of infection to A or N 
transformant type. In Chinese hamster lung cells however, this rela-
tionship was not seen (16}. 
The involvement of the SV40 large T protein in viral DNA repli-
cation and in transformation initiation and maintenance is clear. How 
the large T protein functions to effect these changes is not so well 
known. One way in which SV40 large T protein may mediate some of the 
changes directly or indirectly is through its DNA binding capabilities. 
SV40 large T protein binds both specifically and non-specifically to 
viral or cellular DNA (14,55&102}. It was shown that T antigen has a 
highly specific binding affinity to three DNA sequences which lie in 
the vicinity of the origin of replication at 0.67 map units (55,102}. 
Recent studies by Khandjian et al. (56} suggest that SV40 large T pro-
tein is also capable of binding RNA. They found that small RNA frag-
ments, apparently derived from high molecular weight RNA, remain bound 
to RNAse treated gel purified SV40 T antigen. It is possible that SV40 
T antigen as an RNA binding protein might be involved in the regulation, 
maturation or translation of cellular mRNAs. 
Other findings which may be important in understanding how SV40 
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large T protein functions in transformation include the complex of large 
T protein with cellular proteins. Lane and Crawford (62) first·reported 
that T antigen from a line of SV40 transformed mouse cells formed an 
oligomeric complex with a specific cell coded protein. When they immu-
noprecipitated from an SV40 transformed mouse cell line with antiserum 
raised against purified T, two polypeptides were precipitated. One was 
large T protein, molecular weight 94,000 daltons and the other was a 
cell coded protein, molecular weight 53,000 daltons. This same pattern 
was seen when monoclonal antibody specific for the mouse 53,000 dalton 
protein was used (48). Lane and Crawford (62) went on to prove that the 
large T and 53,000 dalton cellular protein existed in solution as a com-
plex. Others reported that the cellular 53,000 dalton protein was pre-
sent in small amounts in uninfected cells and the amounts increased up 
to 50 fold upon infection when a functional A gene was present (66). 
Lane and Hoeffler reported on a 68,000 dalton nuclear protein 
present in extracts of mouse L cells and other cell lines including hu-
man, monkey, and rat cells, which shared an antigenic determinant with 
large T protein. This 68,000 dalton protein could be detected by in-
direct immunofluorescence with monoclonal antibody in the nuclei of 
cells growing exponentially but to a lesser extent in cells in a quies-
cent state. 
There are a number of other reports of proteins in the 48,000-
84,000 dalton range precipitated from SV40 transformed cells by anti-
tumor serum. These may be non-specific background precipitation, pro-
teins complexed with T, proteolytic breakdown products ofT, or proteins 
which share an anitigenic determinant with T (63,74,106,116). The as-
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sociation of these cellular proteins in specific complexes or by shared 
antigenic determinants with T antigen suggests that they may be ·impor-
tant for the cellular functions required for transformation. 
Two enzymatic activities of SV40 large T protein may be involved 
in the phenotypes of transformation. They are a protein kinase activity 
and an ATPase activity. Conflicting evidence exists as to whether the 
protein kinase activity is inherent in large T protein or simply co-
purified with it. Griffin et al. (46) reported that incubation of SV40 
tumor antigen containing immunoprecipitates with 32 P-ATP resulted in the 
incorporation of radioactive phosphate into large T antigen. They also 
reported that highly purified preparations of large T antigen were able 
to catalyze the phosphorylation of a known phosphate acceptor. Others 
(128) reported that the protein kinase activity associated with large T 
protein was reduced as T purification increased indicating that the pro-
tein kinase activity was not actually a part of the large T protein. In 
contrast however, Griffin et al. (115) showed that the kinase activity 
may be intrinsic in that the activity was reduced at the restrictive 
temperature in extracts from cells infected with ts mutants. This ques-
tion has not been resolved. 
The ability to hydrolyze ATP to ADP is also associated with pu-
rified large T protein (40,129). Rigorous purification of large T pro-
tein did not lead to separation of ATPase activity from large T as pro-
tein kinase activity was separated from large T protein (129). Clark 
et al. (17) utilized monoclonal antibodies as probes of the activity in 
SV40 large T protein. They found that monoclonal antibodies directed 
to the large T protein were capable of inhibiting ATPase activity. Spe-
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cifically, antibodies directed to the region ofT antigen coded from be-
tween 0.37 and 0.29 map units inhibited ATPase activity. These results 
strongly suggest that the ATPase activity is intrinsic to T antigen. 
The ATPase activity of SV40 large T antigen has not been linked to any 
of the known biological functions ofT antigen. 
There is substantial evidence that there are different forms of 
SV40 large T protein. These forms may be the result of fusion products 
of the virus and cellular genome (15,58) or subtle antigenic differences 
(48) but often they are the result of varying levels of phosphorylation. 
Greenspan and Carroll (43) found that SV40 large T protein labeled with 
3H-methionine and 32 P-orthophosphate isoelectric focused as four dis-
tinct species distributed in a highly reproducible pattern. The fact 
that they differed in their 32P; 3H ratios suggested that they were het-
erogeneous in their phosphate content. Fanning et al. (30) characteriz-
ed the multiple forms of simian virus 40 T antigen. They separated 
forms ofT antigen by zone velocity sedimentation in sucrose density 
gradients and found a 5S to 6S form, a 14S to 16S form and a 23S to 25S 
form. Differential labeling indicated that the 5S to 6S form was less 
highly phosphorylated than the faster sedimenting forms. Interestingly, 
monkey cells infected with a tsA mutant of SV40 at the restrictive tem-
perature contained only the 5S to 6S form. After shift to the permis-
sive temperature faster sedimenting forms were seen. Montenarh and 
Henning (75) studied the phosphorylation and DNA binding of SV40 T. 
They found that the higher phosphorylated forms ofT antigen bound more 
strongly to both dsDNA and ssDNA. This observation is consistent with 
the hypothesis that the binding affinities of SV40 T antigen to DNA may 
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be regulated by its phosphorylation. The addition and removal of phos-
phate groups of chromatin associated proteins of eukaryotic cells has 
been suggested as a control mechanism for regulation of DNA binding pro-
perties (93). Greenspan and Carroll (44) reported that the 48,000 
dalton nonviral T associated protein is preferentially complexed with 
the maximally phosphorylated form of large T protein. They also found 
that mutation in the A gene caused a decrease in T antigen phosphoryla-
tion and a marked decrease in the binding to the 48,000 dalton nonviral 
T associated protein. These studies provide evidence for a functional 
inter-relatedness between phosphorylation ofT antigen, DNA binding and 
interaction with cellular proteins. 
Reports of the physical and/or funcional aspects of the BKV large 
and small T proteins have been limited. Of the two viruses, SV40 and 
BKV, the research emphasis has consistently been placed on SV40. Anum-
ber of facts are responsible for this. The first is that SV40 was iso-
lated prior to BKV. Another is that the host range of SV40 provides a 
more accesible supply of cells for growing the virus than does BKV. 
Thirdly because of the first two reasons and because of the known ex-
tensive functional and compositional similarities the emphasis has re-
mained with SV40. 
The BKV T antigens are closely related to those of SV40. 
Dougherty (23) studied the relatedness of the papovavirus T antigens 
using immunoperoxidase assay , different sources of anti-T sera and im-
munoadsorption. He found that BKV anti-tumor serum reacted with other 
papovavirus T antigens but that these T antigens also exhibited some u-
nique antigenic properties. BKV T antigen can be immunoprecipitated 
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with anti-SV40 tumor serum and SV40 T antigen can be immunoprecipitated 
with anti-BKV tumor serum (81 ,96). Tryptic peptide analysis has shown 
that SV40 and BKV T proteins share 7 pairs of tryptic peptides out of 20 
SV40 and 21 BKV specific peptides (108). The small t proteins of BKV 
and SV40 also cross-react immunologically and share tryptic peptides 
(105). 
One naturally occurring variant of BKV is BKV strain MM (BKV-MM). 
BKV-MM was isolated from the brain tumor and urine of a patient with 
Wiskott-Aldrich syndrome (123). The complete sequence of BKV-MM was re-
ported by Yang and Wu (138). The regions from map positions 0 to 0.512 
and 0.699 to 1 .0 on BKV-MM are identical to those of 0 to 0.489 and 
0.7llto 1.0 on BKV-WT. On BKV-MM the region between 0.614 and 0.554 
codes for small t antigen. Within this region is a deletion which would 
yield a 100 amino acid small t instead of a 172 amino acid wild type 
small t. However, Seif et al. (99) have reported that because the dele-
tion removes a donor site for small t mRNA intervening sequences, no 
small tor truncated form of small tis produced. BKV-MM is capable of 
tumor induction in nude mice and stable transformation of growing cells 
(19,73). It is not known if BKV-M~1 can transform cells as efficiently 
as the wild type virus. Further studies of the functional aspects of 
the BKV tumor proteins in transformation are lacking. 
CHAPTER III 
MATERIALS AND METHODS 
Buffers and Solutions 
The composition of buffers and solutions is listed in Table 1. 
Cells and Cell Culture 
Cells were grown in Dulbecco's modified Eagle medium (DME) (1) 
(Flow Laboratories) at 37°C in a moist 7% co2 atmosphere. DME was sup-
plemented with fetal calf serum (FCS) or adult calf serum (CS). 
Baby hamster kidney (BHK-21) cells (119), BK virus (BKV) trans-
formed BHK-21 cells and BKV transformed hamster fibroblast (RF-194) 
cells (23) were grown in DME supplemented with 10% CS and 19% tryptose 
phosphate broth (TPB), (Difco). TPB was a solution of 29.5% TPB in 
distilled H2o. SV40 (simian virus 40) transformed human cell line 
SV80 (130,131) was grown in DME plus 10% CS. Human embryonic kidney 
(HEK) cells were grown in DME plus 10% FCS. SV40 transformed hamster 
fibroblast line THE 2 (95) was grown in DME plus 10% CS. Marmoset brain 
cells (MBC) established by E.O. Major were grown in DME plus 10% FCS. 
Hybridoma cells clones 7, 122, and 412 (7) and 108 from E. Gurney were 
grown in DME plus 20% FCS. 
For routine culture (except for hybridoma cells), cells were 
grown to confluency and washed once with DME. Then 2.0 ml of 0.5% tryp-
sin in versene buffer (pH 7.1) containing 137 mM NaCl, 0.6 mM EDTA, 2.7 
mM KCl, 8.1 mM Na 2Po4, 1.7 mM KH 2Po4 was added. Once the cells detached 
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PBS (cell washing) 
TBS (cell washing) 
Extraction buffer 
Bead swelling buffer 
Bead washing buffer 
Bead elution buffer 














137 mM NaCl, 5.0 mM KCl, 0.7 mM NaHP04, 
8.2 mM Tris 
137 mM NaCl, 0.6 mM EDTA, 2.7 mM KCl 
8.1 mM Na2HP04, 1.7 mM KH2P04 
137 mM NaCl, 2.6 mM KCl, 1.6 mM Na2HP04, 
0.1 mM KH2P04, 0.4 mM MgCl2, 0.9 mM CaCl2 
9 mM Na2HP04, 1 mM NaH2P04, 140 mM NaCl 
20 mM Tris, 137 mM NaCl, mM CaCl2, 
1 mM MgCl2 
20 mM Tris, 137 mM NaCl, l mM CaCl2, 
1 mM MgCl2, 10% glycerol, 0.75% NP 40, 
l ~1/ml of a 50 mg/ml solution of PMSF 
in 100% ethano 1 
20 mM Tris, 137 mM NaCl 
100 mM Tris, 500 mM LiCl, 1% 2-mercapthoethanol 
20 mM Tris, 20% glycerol, 5% SDS, 
5% 2-mercaptoethanol, 0.001% bromophenol blue 
375 mM Tris, 0.1% SDS 
Tab 1 e 1 
Buffer Used pH 
Electrode buffer 8.1 
DNA cellulose column 
washing buffer 6.0 
DNA cellulose column 
e 1 uti on buffer 9.0 
TES 7. 1 
TNE 7.4 
Agarose gel electrophoresis 
buffer 8. 1 
Restriction endonuclease 
reaction buffer 7.4 
25 mM Tris, 
5 mM K2HP04 
20 mM Tri s 
50 mM Tris, 
10 mM Tris, 
89 mM Tri s, 
10 mM Tri s, 
Contents 
192 mM glycine, 0.1% SDS 
100 mM NaCl, 10 mM EDTA 
100 mM NaCl, 1 mM EDTA 
89 mM boric acid, 25 mM EDTA 
50 mM NaCl, 10 mM MgS04 
N 
(.]1 
they were washed once in DME, counted, and except where indicated 
5 plated at 3 X 10 cells/60 mm or 100 mm tissue culture plate, or they 
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were frozen at 4 X 106 cells/vial in 70% DME, 20% serum, 10% dimethyl-
s ul foxi de. 
When hybridoma cells reached densities of approximately 9 X 106 
cells/100 mm tissue culture dish they were harvested, counted and plat-
ed at 3 X 105 cells/100 mm tissue culture dish or they were frozen at 
4 X 106 cells/1.5 ml vial in 40% DME, 50% FCS, and 10% DMSO. 
Virus Growth and Purification 
The BKV stock used in these studies was prepared in the fol-
lowing way. HEK cells were grown to semi-confluency and were infected 
with the Gardner strain (36) of BKV (plaque isolate 18), at a multipli-
city of infection (m.o.i) of 0.1 plaque forming units (pfu)/cell. The 
virus was allowed to adsorb for two hours. The cells were then refed 
with DME plus 1% FCS. BKV plaque isolate 18 was harvested 10 days post-
infection and BKV-MM was harvested 12 days post-infection. 
Virus was purified according to the method of Wright and 
di Mayorca (136). After scraping the infected cells into the media the 
material was subjected to six cycles of freezing and thawing in a dry 
ice-acetone bath. The cellular debris was removed by centrifugation at 
10,000 X g for 5 min at 4°C. The supernatant was then centrifuged at 
64,000 X g for 3 h at 20°C over a cushion of 10.0 ml of saturated K9r 
solution in TO buffer (pH 7.0) containing 137 mM NaCl, 5.0 mM KCl, 0.7 
mM Na 2HP04 , 8.2 mM tris(hydroxymethyl) aminomethane (Tris). The visible 
band of virus was collected and dialyzed against 3 changes of TO buffer. 
The volume of the dialyzed material was brought to 7.5 ml with TO buffer 
27 
added to 3.45 g of CsCl and placed in a cellulose nitrate centrifuge 
tube. The solution was centrifuged at 74,000 X g for 18 h at 20°C. The 
virus band formed near a density of 1.3451. It was removed with a sy-
ringe and 21 gauge needle, dialyzed against 3 changes of TD buffer and 
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stored at -70 C. 
Plague Assay for Determination of Virus Titer 
HEK cells were plated onto 60 mm tissue culture plates at 3 X 
105 cells/plate. They were allowed to grow to confluency. The media 
was removed from the plates and the cells were washed once with DME. 
The virus sample was diluted in 10 fold serial dilutions. After wash-
ing the cells with DME 0.4 ml of each dilution was plated onto cell 
monolayers in triplicate. The virus particles were allowed to adsorb 
for l h. Then 9.0 ml of 0.9% agar in DME plus 1% FCS was added. 
Plaques were allowed to develop for 12 days. At the end of 12 days the 
monolayers were overlayered a second time with 5.0 ml of 0.9% agar in 
DME plus 1% FCS and 0.0005% neutral red dye. The neutral red dye stain-
ed only the viable cells leaving the plaques as clear areas which could 
easily be visualized. 
Virus Transformation Assay 
BHK-21 cells were treated with virus in suspension and plated 
in soft (0.33%) agar based on the method of MacPhearson and Montagnier 
(68). BHK-21 cells were harvested with 0.5% trypsin in versene buffer 
and resuspended in TD buffer supplemented with 1% CS previously filtered 
through a 0.45 ~M filter to a concentration of l X 107 cells/ml. A 
0.05 ml aliquot of this suspension containing 5 X 105 cells was placed 
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in each tube for virus transformation and in one control tube with no 
virus added. To each tube for virus transformation 100 pfu/cell of vi-
rus was added. The volume in all tubes was adjusted to 0.5 ml with TD 
buffer supplemented with 1% filtered calf serum. A 5.0 ml long stir-
ring bar was added. The tubes were securely sealed to prevent evapor-
ation and they were incubated for 1 h, 37°C with constant, gentle stir-
ring. 
Following incubation any large clumps of cells were broken up 
by drawing the cells up and down through a pasteur pipette drawn out to 
capillary size. A 0.2 ml portion of the cell-virus mixture was then 
added to 4.8 ml Eagle's diluent consisting of 10% filtered calf serum, 
10% TPB, and 80% lX DME. 10 ml of top agar containing 10% calf serum, 
10% TPB, 40% 2X DME and 40% 1.275% agar was added to this and 1.5 ml 
was pipetted onto plates containing 5 ml bottom agar. Bottom agar con-
tained 10% calf serum, 10% TPB, 40% 2X DME, and 40% 1.275% agar. 
Colonies could be visualized macroscopically after 3-4 weeks of 
incubation at 37°C. When the colonies were approximately 1 mm in diame-
ter they were counted and the efficiency of transformation was calcu-
lated. This was done by dividing the number of visible colonies/plate 
by the total number of cells palted/plate and multiplying by 100. The 
average value from 10 plates was taken. Colonies were then taken from 
agar with a pasteur pipette. They were dispersed and plated in 60 mm 
tissue culture plates. When the plates were semi-confluent the cells 
were harvested and transferred to 100 mm tissue culture plates. They 
were then studied immediately or stored for later use. BKV transformed 
BHK-21 cell clones were distinguished by a letter and a number. 
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flating Efficiency of Transformed Cells in Soft Agar 
Cells were harvested, counted and resuspended to 1.0 X 1.0 6 
cells/ml in DME. A 0.1 ml portion of this suspension was added to 1.9 
ml DME to give 5 X 104 cells/ml. To 4.8 ml Eagle's diluent was added 
0.2 ml of the diluted suspension. This suspension was then added to 
10.0 ml of top agar consisting of 40% 2 X DME, 40% 1.275% agar, 10% fil-
tered calf serum and 1.5 ml was plated onto each of 10 plates containing 
5.0 ml bottom agar. Bottom agar consists of 40% 1.275% agar, 40% 2X 
DME, 10% TPB and 10% CS. Colonies were counted when they were approxi-
mately 2 mm in diameter. The plating efficiency was calculated by di-
viding the number of colonies counted/plate by the total number of cells 
and multiplying by 100. The values represent an average from 10 plates. 
Subcloning 
BK-BHK C7 passage 23 (TC 23) was harvested, counted, and diluted 
to cell every 0.2 ml in DME with 10% CS and 10% TPB. Cells were plat-
ed into 4, 96 well cloning plates, 0.2 ml/well. Immediately after plat-
ing wells were checked microscopically to determine which had received 
single cells. Fifteen days past plating 56 clones originating from 
single cells were harvested and plated into 30 mm tissue culture clon-
ing dishes. Of these subclones 10 were randomly selected for further 
study . They were designated as subclones by the letters SC. 
Growth Curves 
Cells were plated at 3 X 105/60 mm tissue culture plate in DME 
plus 1% CS, 1% TPB, or in DME plus 10% CS, 10% TPB. They were not refed. 
Cells were harvested and counted 1, 2, 3, and 7 days past plating. Val-
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ues represent the average of two plates counted. 
Ce 11 Fusion 
Cell fusion with polyethylene glycol (PEG) and dimethyl sulfox-
ide was done based on the method described by Norwood et al. (78). HEK 
cells were plated at 3 X 105 cells/60 mm tissue plate and allowed to 
grow for 48 h or until semi-confluent. BK-BHK transformants were plated 
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on top at 5 X 10 cells/plate and allowed to grow for 24 h. For fusion 
8.0 g of PEG, molecular weight 6,000 were autoclaved and immediately 
mixed with 10.0 ml of DME plus 15% DMSO. The media was removed from the 
plates and the cells were washed once with DME. A 2.0 ml portion of the 
PEG-DMSO-DME mixture was applied to the cells for 1 min and then remov-
ed by aspiration. The cells were washed four times with DME plus 15% 
DMSO and twice with DME and refed with DME plus 2% FCS. After three 
days the cells were harvested by scraping them off the plate with a rub-
ber policeman and frozen and thawed in a dry ice-acetone bath. Cellular 
debris was removed by centrifugation at 10,000 x g for 5 min at 4°C. 
The presence of virus in the supernatant was determined by plaque assay. 
Antiserum Production 
Antiserum was produced to BKV and SV40 transformed cells using 
RF194 and THE 2 cell lines. RF194 cells were harvested in versene buf-
fer, washed with PBS (pH 7.1) containing 137 mM NaCl, 2.6 mM KCl, 1.6 
mM Na 2HP04, 0.4mM MgC1 2, and 0.9 mM CaCl 2, and counted. Female Syrian 
Golden weanling hamsters were injected with 2.0 X 104 or 2.0 X 10 5 cells 
in 0.5 ml PBS, subcutaneously over the right or left shoulder. Tumors 
were allowed to develop until they were 3-4 em in diameter. This was 
from 3-4 weeks. Hamsters were anesthetized with an intraperitoneal in-
jection of sodium pentobarbital (50 mg/ml) and exsanguinated by car-
diac puncture. From each hamster approximately 3.0 ml of blood could 
be obtained. Serum was collected and stored at -70°C. 
31 
THE 2 cells were grown to semi-confluency, harvested in versene 
buffer and counted. Hamsters were injected with 1 X 105 or 1 X 106 
cells in 0.5 ml PBS subcutaneously over the right or left shoulder. The 
tumors were allowed to develop until they were approximately 4.0 em in 
diameter. This was different for each hamster and ranged from 4-15 
months. Blood was collected as described for RF-194 cell antiserum. 
Hybridoma cells were fused, isolated, and supplied by E. Gurney 
Balb/c mice were immunized with SV40 transformed Balb/c mouse cells. 
Spleen cells from these mice were then fused with mouse myeloma NS-1 
cells. Hybrids secreting antibody to the SV40 T proteins were selected 
for further study. 
Where indicated culture fluid or ascites fluid was used as a 
source of monoclonal anti-T antibody. Cult0re fluid was harvested from 
cell cultures with approximately 9 X 106 cells/100 mm tissue culture 
plate. Cells were pelletted by low speed centrifugation and culture 
fluid was stored at -70°C. 
For ascites production young adult Balb/c mice were given intra-
peritoneal injections of 0.5 ml of 2,6,10,14-Tetramethylpentadecane 
(pristane). Six weeks later each mouse was injected intraperitoneally 
with 1 X 107 cells in 0.5 ml DME. Ascites fluid was drained with a 22 
gauge needle and syringe 2-3 weeks after the cell injections. Fluid 
was centrifuged at 40,000 x g for 30 min, 4°C. Supernatant was re-
moved and stored at -70°C. 
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Indirect Immunofluorescence 
Indirect immunofluorescence (IFA) was done based on a method de-
scribed by Pope and Rowe (85). Cells were grown on 20 X 20 mm cover-
slips placed in 60 mm tissue culture dishes. When the cells were semi-
confluent the coverslips were removed and washed twice in PBS (pH 7.1) 
for 5 min. They were then fixed in acetone for 10 min. Following this 
they were washed twice in PBS for 5 min. Coverslips were then overlaid 
with the indicated dilution of antiserum and incubated at 37°C for 1 h. 
After incubation coverslips were washed three times in PBS for 5 min. 
Coverslips were then overlaid with the indicated dilution of either 
fluorescein isothiocyanate (FITC) conjugated rabbit anti-hamster IgG 
(Cappel Laboratories) or FITC conjugated goat anti-mouse IgG (Cappel 
Laboratories). They were then incubated for 1 hat 37°C. Following in-
cubation they were washed three times in PBS, 5 min each, and mounted in 
buffered glycerol. The cells were examined with a Zeis fluorescent mi-
croscope and photographed with a Nikon camera on Kodak Ektachrome ASA 
400 film at 160X or 400X magnification. Positive and negative cells were 
counted in random fields at 400X magnification. 
Where indicated the cells were prepared for IFA with the use of 
a Shandon Cytospin 2. Cells were harvested with trypsin, washed twice 
in PBS, counted, and diluted to approximately 1 X 107 cells/ml. A 0.1 
ml portion of this was placed in each cytospin funnel and the cells 
were spun onto slides at 65 x g for 5 min. Slides were allowed to dry 
and then were immediately fixed. IFA was then done as described for 
cells grown on coverslips. 
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35s-Methionine Cell Labeling and Extraction 
Except where indicated cells were labeled and extracted accord-
ing to the following method. Cells were grown to a semi-confluent state 
in 100 mm tissue culture plates, and washed once with Earle's minimal 
essential media (MEM) without methionine (Gibco). They were then refed 
with 2.0 ml of MEM without methionine for 30 min. The medium was re-
moved. The cells were labeled with 0.1 mCi 35s-methionine (1200 Ci/mMol) 
in 1.0 ml MEM without methionine for 3 h, 37°C. 
Cells were then extracted based on methods described by 
Schaffhausen et al. (97) and Griffin et al. (45). After the 3 h label-
ing period the medium was removed and the cells were washed twice in 
phosphate buffered saline containing 10 mM sodium phosphate (pH 7.4), 
100 mM NaCl at 4°C. They were then washed three times with Tris buffer-
ed saline (TBS) cell washing buffer containing 20 mM Tris, (pH 9.0), 
137 mM NaCl, 1 mM CaC1 2, 1 mM MgC1 2 at 4°C. Cells were then extracted 
with 1.0 ml of extraction buffer containing 20 mM Tris-HCl (pH 9.0), 
137 mM NaCl, 10% glycerol, 0.75% NP-40, 1 mM CaC1 2, 1 mM MgC1 2 and 1 ~1 
of a 50 mg/ml solution of phenylmethylsulfonyl fluoride (PMSF) in 100% 
ethanol. Extraction was carried out for 30 min at 4°C. The extracts 
were then centrifuged at 40,000 x g for 30 min at 4°C and the superna-
tants were removed. 
Immunoprecipitation 
Cell extracts were immunoprecipitated according to the methods 
of Griffin et al. (45) and Schaffhausen et al. (97). Immunoprecipitat-
tion was carried out either in silicone coated glass tubes or in 1.5 ml 
plastic microfuge tubes. The cell extracts were incubated with 15 wl 
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of hamster antiserum or normal hamster serum for 30 min at 4°C. Protein 
A-Sepharose beads (Pharmacia) (2 mg protein A/ml of swollen gel) were 
swollen in bead swelling buffer consisting of 20 mM Tris-HCl (pH 9.0) 
and 137 mM NaCl for 30 min at 4°C. They were then washed twice in this 
buffer. A volume of 80 ~1 of swollen beads (22 mg dry weight) was ad-
ded to the extracts and incubated at 4°C for 1 h with mixing. The beads 
were then washed three times in bead washing buffer consisting of 100 
mM Tris-HCl (pH 9.0), 500 mM LiCl and 1% 2-mercaptoethanol, 4°C. Wash-
ing was performed using low speed centrifugation in a Sorvall model RC5 
at 4°C or in a Fisher microfuge at 4°C. Immune complexes were eluted 
from the beads with 50 ~1 of bead elution buffer containing 20 mM Tris-
HCl (pH 9.0), 5.0% sodium dodecyl sulfate (SDS), 20% glycerol, 5% 2-mer-
captoethanol, and 0.001% bromophenol blue at 85°C for 5 min. 
Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis was done based on the method 
of Laemmli (60). Except where indicated the separating gel consisted of 
13% acrylamide in separating gel buffer, 0.375 M Tris-HCl (pH 8.7), 0.1% 
SDS. Acrylamide and methylenebisacrylamide (bis) were added in a 37:1 
ratio. Ammonium persulfate was added to 0.025% and the acrylamide solu-
tion was deaerated under vacuum for 5 min. Following deaeration 0.025% 
N ,N ,N 1 ,N 1 -tetramethyl ethyl enedi amine (TEMED) was added. The separating 
gel acrylamide was then poured between 2, 19Xl9 em acid cleaned glass 
plates separated by two 1.5 mm thick spacers on both sides. The bottom 
was plugged with 1% agarose in separating gel buffer. The separating 
gel was then overlaid with distilled H2o and allowed to polymerize. 
After polymerization the H20 was removed and the surface was washed with 
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stacking gel solution. The stacking gel consisted of 5% acrylamide and 
Bis in a 20:1 ratio in stacking gel buffer. Stacking gel buffer ·con-
sisted of 125 m~1 Tris-HCl (pH fi.8), 0.1% SDS. Ammonium persulfate was 
added to 0.25% and the solution was deaerated for 5 min under vacuum. 
Following deaeration 0.25% TEMED was added. The stacking gel was then 
poured on top of the separating gel to a depth of 1.5 em and the sample 
well former was inserted. 
Following polymerization the gel was placed in position between 
the top and bottom buffer chambers. The electrode buffer, consisting of 
25 mM Tris, 192 mM glycine, and 0.1% SDS was added to each chamber. 
Each sample (20 wl) was applied to the gel. Except where indicated gels 
were electrophoresed at 7 rnA constant current overnight, 12-16 h. 
Polyacrylamide Gel Staining 
Gels were fixed and stained in a solution containing 50% metha-
nol, 9.2% glacial acetic acid and 0.25% Coomassie Brilliant Blue R 250 
(Bio Rad) for 6 h. Insoluble material in the solution was removed by 
filtration before staining. Gels were destained overnight in a solution 
containing 5% methanol and 7.5% glacial acetic acid. Destaining was en-
hanced by the addition of diethylaminoethyl (DEAE) cellulose to the de-
staining solution. 
Polyacrylamide Gel Fluorography 
Fluorography was done based on a method described by Bonner and 
Laskey (7). After staining and destaining the gel was rinsed briefly in 
H2o, soaked in 3 changes of DMSO 30 min each, and then immersed in 200 
ml of 22.2% 2,5 diphenyloxazole (PPO) for 3 h. The PPO was then preci-
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pitated in the gel by immersing the gel in H2o for 1 h. The gel was 
then dried in a gel s 1 ab dryer ( Bi o Rad) for 6 h. Kodak Roy a 1 X-Omat 
R film or Kodak Royal X-Omat XAR-5 film was then exposed by the gel at 
-70°C for the desired length of time (usually 1-2 weeks). 
Molecular weights of proteins were determined by comparison with 
those of known protein markers which were visualized by staining. Pro-
tein molecular weight markers (Bio Rad) were phosphorylase B-94,000 dal-
tons, bovine serum albumin-68,000 daltons, ovalbumin-43,000 daltons, 
carbonic anhydrase-30,000 daltons, soybean trypsin inhibitor-21,000 dal-
tons and lysozyme-14,300 daltons. 
DNA Cellulose Chromatography 
DNA cellulose chromatography was done based on methods described 
by Alberts and Herrick (1) and by methods described by K. Rundell (per-
sonal communication). Cellulose was prepared by washing 50 g cellulose 
410 (Bio Rad) twice with 300 ml of boiling 95% ethanol and once with 
200 ml of 0.1 M NaOH, 1.0 mM EDTA. Cellulose was then washed once with 
200 ml of 10 mM HCl followed by washing 3 times in distilled H2o. DNA-
cellulose was prepared by dissolving 60 mg calf thymus DNA (Calbiochem) 
in 30 ml of 10 mM Tris-HCl (pH 7.4), 1 mM EDTA, then slowly adding 1e g 
of prepared cellulose. The resulting paste was spread on the sides of a 
beaker and allowed to dry slowly for several days. After drying the 
DNA cellulose was ground to a powder with a mortar and pestle. 
The chromatography wa~ done by first washing 5.0 g DNA-cellulose 
3 times in 5 mM K2HP0 4 (pH 6.0). DNA cellulose was poured into a pas-
teur pipette plugged with glass wool, and allowed to pack to a length of 
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2.5 em. A 1.0 ml sample (cell lysate from one 100 mm tissue culture 
plate) was adjusted to pH 6.0 with 0.2 ml of 200 mM sodium pho~phate 
and then applied to the column. The column was then washed twice with 
1.0 ml of 5 mM K2HP04 (pH 6.0). Any proteins capable of binding at pH 
6.0 and eluting at pH 9.0 were released from the DNA-cellulose by ad-
ding 1.5 ml of 20 mM Tris-HCl (pH 9.0). The pH 9.0 final sample was 
collected and the fractions were immunoprecipitated. To precipitate 
from a pH 6.0 sample the pH was first adjusted back to pH 8.0-9.0 with 
0.2 ml of 1 M Tris-HCl, pH 9.0. 
Hirt Extraction of Viral DNA 
HEK cells were infected with a m.o.i. of 1 pfu/cell of either 
wild type BKV or BKV-MM. DNA was extracted 7 days after infection for 
wild type BKV and 12 days after infection for BKV-MM, according to the 
method of Hirt (51). Monolayers were washed 3 times in TES buffer con-
taining 50 mM Tris-HCl (pH 7.1), 100 mM NaCl, 10 mM EDTA. To each plate 
1.0 ml of TES with 0.6% SDS was added and incubated 10 min, 37°C. The 
lysed cells were gently scraped into a Corex tube number 8445. A volume 
of 5.0 M NaCl was added so that the final concentration of NaCl was 1.0 
M. The tubes were covered, mixed gently and refrigerated overnight at 
4°C. The samples were then centrifiged at 40,000 x g for 15 min, 4°C. 
The supernatants were poured into rinsed Corex tubes number 8445, 2 vol-
umes of 100% ethanol at -20°C were added and the tubes were mixed gent-
ly. They were then refrigerated overnight at -20°C followed by centri-
o fugation at 27,000 x g for 1 h, 4 C. The supernatant was removed, 2.0 
ml of TES plus 0.1 ml of a mg/ml solution of pronase was added and 
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the tubes were placed in a 37°C waterbath overnight. Following pronase 
digestion 1 volume of phenol was added and the tubes were gently mixed 
and then centrifuged at 3,000 x g for 5 mini 4°C to separate the phases. 
The aqueous layer was extracted. Then 1 volume of chloroform-isoamyl 
alcohol (24:1 v/v) was added, tubes gently mixed and then centrifuged at 
3,000 x g for 5 min, 4°C. The top layer was removed. The DNA was then 
precipitated with 100% ethanol, -20°C, then refrigerated at -20°C over-
night. It was then centrifuged at 27,000 x g for 1 h, 4°C. The super-
natant was removed and the DNA dissolved in 0.3 ml of TES buffer. 
Restriction Endonuclease Cleavage of Viral DNA 
Viral DNA was cleaved by restriction endonuclease Hind III ac-
cording to the following method. The digestion was carried out with 
20 ~1 reaction buffer, 3 ~g DNA, and 15 units enzyme for 60 min 37°C. 
Reaction buffer contained 10 mM Tris {pH 7.4), 50 mM NaCl, 10 mM MgS04. 
The reaction was stopped by the addition of 10 ~1 of tracking dye. 
Tracking dye contained 10% SDS, 5% glycerol, and 0.001% bromophenol blue. 
Agarose Gel Electrophoresis 
The DNA cleavage fragments were separated by electrophoresis in 
a 1.2% horizontal agarose gel. The gel and chamber buffer consisted of 
89 mM Tris, 89 mM boric acid {pH 8,1), and 25 mM EDTA. Samples were 
electrophoresed overnight at 10 rnA, constant current. The gel was 
stained in a solution of 2 ~g of ethidium bromide/ml of H20 for 3 h and 
destained in H2o for 3 h. The gel was phorographed on an ultraviolet 
transilluminator with a Polaroid MP-4 Land camera and Polaroid Type 52 
Land film. Molecular weights of the DNA fragments were determined by 
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comparison with those of known DNA fragments from a Hind III digest of 
lambda DNA (New England Biolabs). 
Cell Cycle Synchronization 
Cells were synchronized with 1 mM hydroxyurea based on a method 
first described by Dubbs and Kit (25) and modified by Lanford and Butel 
(64). Cells were plated at 3 X 105;60 mm tissue culture plate in DME 
plus 0.1% CS and 0.1% TPB and allowed to grow 24 h. After 24 h the me-
dium was replaced with DME plus 10% CS, 10% TPB, 1 mM hydroxyurea. 
Cells were incubated another 18 h, the medium was removed and the cells 
washed once in DME. The medium was replaced with DME plus 10% CS, 10% 
TPB. At various times after release from the block cells were pulse 
labeled for 30 min in DME containing 10% CS, 10% TPB, and 2.5 ~Ci/ml of 
3H-thymidine (67 Ci/mmol) (ICN). The pulse was terminated by putting 
the cultures on ice. Cells were then scraped into the media and washed 
3 times in 10 mM Tris (pH 7.4), 100 mM NaCl, 1 mM EDTA. Cells were 
resuspended in 3.0 ml of TNE and lysed by adding 75 ~1 of 10% SDS for 
10 min, 25°C. Samples were deproteinized by treatment with 60 ~1 of a 
solution of 1 mg/ml pronase at 37°C for 30 min. A 100 ~1 sample was 
then spotted and dried in duplicate on GF/A filter discs (Whatman). 
They were then washed once in 10% trichloracetic acid (TCA), once in 
5% TCA, and once in 95% ethanol for 5 min/wash. Filters were dried and 
counted in 5.0 ml of scintillation fluid containing 25% triton X-100 
(Beckman Scientific), 2% liquid Spectrafluor PPO(Amersham), 73% scin-
tillation grade toluene (Beckman Scientific) with a Beckman LS 8000 
scintillation counter. Fifteen minutes into each pulse cells were har-





Characteristics of BKV Transformed BHK-21 Cells 
For these studies BHK-21 cells were exposed to BKV and the re-
sulting transformants were selected for their ability to grow in soft 
0.33% agar suspension. Cells exposed to virus grew in 0.33% agar at a 
transformation frequency of 0.70% whether they were exposed to 101, 10 2, 
or 103 pfu/cell of virus. The control sample of cells not exposed to 
virus grew in 0.33% agar at 0.04% frequency. 
Twelve of these clones were taken from the 0.33% agar and stud-
ied further. One clone (L29) was generated previously (80). There-
sults of some of these studies are shown in Table 2. The transformed 
phenotype of these clones was shown by increased plating efficiency in 
0.33% agar. BHK-21 cells not exposed to virus plated in 0.33% agar with 
an efficiency of 0.6%. Cells exposed to virus, selected in soft agar 
then grown up and replated in soft agar plated with efficiencies rang-
ing from 2.6% to 15.0%. The association of virus with these cells was 
shown by virus rescue. The virus rescue titer/ml of lysate was deter--
mined for each clone. Since only 1.0 ml of lysate was tested for virus 
clones with titers of 1.0 X 10°/ml were rescue negative in this assay. 
Rescue positive clones had titers ranging from 5.8 X 102/ml to 6.0 X 
10 3/ml. Only transformed cells fused with permissive HEK cells rescued 
virus. Transformed cells fused with themselves did not yield detecta-
ble virus. The nuclear T antigen reactivity as reported in Table 2 
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Tab 1 e 2 CHARACTERISTICS OF BKV TRANSFORMED BHK-21 CLONES 
Plating Efficiency in 
Clone Soft Agar b Virus Rescue Titer/ml Lysate b T Antigen Reactivitya 
BK-BHK A1 12.9% 5.8 X 102 Positive 
BK-BHK A4 4.6% 4.5 X 103 Positive 
BK-BHK A7 9.9% < 1.0 X 100 Negative 
BK-BHK As 12.7% < 1.0 X 10° Negative 
BK-BHK B2 8.6% < 1 .0 X 100 Negative 
BK-BHK B8 11 .5% 2.8 X 103 Positive 
BK-BHK c1 2.6% 4.0 x 1 o3 Positive 
BK-BHK c2 6.4% < 1 .0 X 10° Positive 
BK-BHK C4 5.9% 4.5 X 103 Positive 
BK-BHK c7 12.0% 6.0 X 103 Positive 
BK-BHK c8 10.2% < 1 .0 X 100 Negative 
BK-BHK C1o 10.7% 1.8 X 103 Positive 
BK-BHK L29 15.0% 1.0 X 103 Positive 
BHK-21 0.6% < 1 .0 X 10° Negative 
a T antigen detection was carried out by IFA with anti-THE 2 tumor serum. Positive or negative reactivity 
as reported here was determined by the presence or absence of positive nuclei regardless of the number 
of positive nuclei or the tissue culture passage number. 
b Plating efficiency in soft agar and virus rescue titer were done as described in Materials and Methods. 
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was determined by IFA with anti-THE 2 antiserum. Clones were identified 
as positive if any positive nuclei were seen regardless of the number 
of positive nuclei or the tissue culture passage number. Four out of 
thirteen clones were negative. These 4 were also rescue negative. One 
clone, BK-BHK C2 was rescue negative butT antigen positive. The cells 
of a positive clone were never uniformly positive. As compared with 
the SV40 transformed human cell line SV80 shown in Figure 1 which is 
100% T positive BK-BHK clones were usually less than 10% positive. 
Photographs of the Cl clone and the A4 clone are shown in Figures 2 and 
3. Two negative clones are shown in Figure 4. Positive cells often 
appeared in clusters. Controls included with each assay included BHK-
21 cells reacted with anti-THE 2 serum and SV80 cells with anti-THE 2 
serum. BHK-21 cells were never positive and SV80 cells were always 
100% positive. The transformed clones were also reacted with normal 
hamster serum and were always completely negative. 
The relationship between tissue culture passage number and the 
percentage of positive nuclei within each clone was examined. In 5 out 
of 6 clones the number of positive nuclei increased with passage in cul-
ture. The sixth clone C8 did not show an increase through 10 passages. 
The C8 clone was rescue negative. In Figure 5 are photographs of clone 
L29 passage 20 and passage 59. Both were assayed at the same time. 
The cells were reacted with anti-THE2 serum and stained with fluorescein 
conjugated rabbit anti-hamster IgG as described for IFA. At passage 20 
clone L29 was <0.1% positive and at passage 59 it was 9.4% positive. 
The passage at which the percentage of positive nuclei began to increase 
varied with each clone. For L29 this was after passage 20, for Al af-
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Figure 1. IFA assay of SV80 cells reacted with anti-THE2 serum. 
Initial magnification 160X. 
45 
46 
Figure 2. IFA of BK-BHK clone Cl TC13 reacted with anti-THE2 se-
rum. Initial magnification 160X. 
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Figure 3. IFA of BK-BHK A4 TC7 reacted with anti-THE 2 serum. A, 




Figure 4. A. IFA of BK-BHK clone C8 TC6 reacted with anti-THE2 
serum. B. IFA of BK-BHK clone A7 TC6 reacted with anti-THE2 serum. 
Initial magnification for both 160X. 
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Figure 5. A. IFA of BK-BHK TC20 reacted with anti-THE 2 serum. 
B. IFA of BK-BHK L29 TC59 reacted with anti-THE 2 serum. Initial 
magnification for both l60X. 
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Tab 1 e 3 CONTINUAL PASSAGE DETECTION OF TUMOR PROTEINS 
BK-BHK C1 one Passage Number Percent Positive a 
L29 16 < 0.1 













5 < 0. 1 
6 < 0.1 
9 < 0.1 
10 < 0.1 



















l 0. 0 
Tumor proteins were detected by IFA with anti-THE2 serum. The percent positive reflects the 
number of positive nuclei counted in a total of 1000 cells. 
U1 
U1 
Antiserum and Detection of BKV Tumor Proteins from Lytically Infected 
Cells 
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Antiserum was first made in hamsters against BKV transformed 
BHK-21 (RF-194) cells. When 2 X 105 cells were injected hamsters were 
exsanguinated 4-7 weeks after injection as shown in Table 4. The capa-
city of this antiserum to detect the BKV large and small T proteins was 
tested by immunoprecipitation from BKV infected HEK cells. The results 
are shown in Figure 6. This antiserum precipitated a 94,000 dalton pro-
tein which was not precipitated by normal serum. This 94,000 dalton 
protein comigrated with the SV40 large T protein precipitated from SV80 
cells (Figure 13) and is probably the BKV large T protein. The anti-
RF194 serum did not precipitate a protein in the 17,000-22,000 dalton 
range which would be consistent with a small t protein. When 2 X 104 
RF194 cells were injected (Table 4) hamsters were exsanguinated 6-7 
weeks after injection. This antiserum also could not precipitate a pro-
tein of a molecular weight consistent with estimates for the molecular 
weight of BKV small t protein. 
When SV40 transformed hamster cells were used to immunize ham-
sters the tumor development was much slower and hamsters were exsangui-
nated 21-67 weeks after inoculation as shown in Table 4. Antiserum to 
THE 2 cells immunoprecipitated a 94,000 dalton protein from BKV infected 
HEK cells as shown in Figure 7. It also precipitated a 22,000 dalton 
protein which was not precipitated with normal serum. This 22,000 dal-
ton protein comigrated with the SV40 small t protein from SV80 cells 
(see Figure 13). 
When BKV infected marmoset brain cells were immunoprecipitated 
Tab 1 e 4 ANTISERUM PRODUCTION 
a 
Cell Type Cell Number/Hamster Number of Hamsters 
RF194 2 X 104 7 





The period of time from inoculation, through tumor development to exsanguination. 









Figure 6. Polyacrylamide gel autoradiograph of immunoprecipita-
tion from BKV lytically infected extracts of 35s-methionine labeled 
HEK cells with anti-RF194 serum (T.S.) and normal hamster serum 
(N.S.). Cells were infected with lOpfu of BKV/cell for 5 days then 
extracted and immunoprecipitated. Electrophoresis was at 75 rnA 






Figure 7. Polyacrylamide gel autoradiograph of BKV lytically in-
f t d 35s th. . 1 b 1 d HEK 11 t t . . . t t d ec e -me 10n1ne a e e ce ex rae 1mmunoprec1p1 a e 
with anti-THE 2 serum. Cells were infected with 10 pfu/cell of BKV 
for 3 days then immunoprecipitated. Electrophoresis was at 75 rnA 
for 4.5 h. Lane A, precipitated with notmal hamster serum. Lane 




with anti-THE2 serum a 94,000 dalton protein was present which was not 
precipitated with normal hamster serum. This is consistent with the BKV 
large T protein. Two proteins which migrated to a molecular weight 
range consistent with small t protein were precipitated with anti-THE 2 
serum. One protein migrated at 22,000 daltons and another at 18,000 dal-
tons. Neither were precipitated with normal hamster serum. These results 
are shown in Figure 8. 
Hybridoma cells producing monoclonal antibodies directed against 
SV40 tumor proteins were obtained from E. Gurney. These were clones 7, 
412, 122, and 108. Clones 7, 412 and 108 were specific for SV40 large T 
protein and clone 122 was specific for the 53,000 dalton nonviral protein 
which co-precipitated the large T protein (7). Clones 7, 412, and 122 
were used to generate ascites fluid in mice. Clone 7 and 412 ascites 
fluids were titered on SV80 cells using indirect immunofluorescence. 
Nuclear SV40 T protein reactivity titered at 1:3000 for both ascites 
fluids. Clone 7,412, and 122 ascites fluids were then used to immuno-
precipitate from BKV infected HEK cells. The results are shown in Fig-
ure 9. Clone 412 was capable of precipitating the SV40 large T protein 
from SV80 cells as shown in lane E. Clone 412 could not precipitate the 
BKV large T protein as shown in lane C. Clone 7 could not precipitate 
the BKV large T protein as shown in lane B. Clone 122 ascites fluid did 
not precipitate theBKV large T protein as shown in lane A. Lane D, BKV 
infected HEK cell extract precipitated with anti-THE serum demonstrates 
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the presence of BKV large T protein in these extracts. Clone 108 was 
tested separately. The clone 108 culture fluid was incapable of immuno-




Figure 8. Polyacrylamide gel autoradiograph of immunoprecipita-
tion from extracts of BKV infected 35s-methionine labeled marmo-
set brain cells with anti-THE 2 serum (lane A) and normal hamster 
serum (lane B). Cells were infected with BKV at 10 pfu/cell. 
After 8 days they were labeled, extracted and immunoprecipitated. 






Figure 9. Polyacrylamide gel autoradiograph of 35s-methionine 
labeled, monoclonal antibody precipitated extracts. Lane A, BKV 
lytically infected HEK cell extract precipitated with 200 ~1 clone 
122 ascites fluid. Lane B, BKV lytically infected HEK cell ex-
tract precipitated with 200 ~1 clone 412 ascites fluid. Lane C, 
BKV lytically infected HEK cell extract precipitated with 200 ~1 
of clone 7 ascites fluid. Lane 0, extract after precipitation 
with clone 412 antibody, precipitated with 20 ~1 anti-THE2 serum. 
Lane E, SV80 cell extract precipitated with 200 ~1 of clone 412 
ascites fluid. HEK cells were infected with 1 pfu/cell of BKV 
for 7 days before labeling. Electrophoresis was at 7 rnA over-
night. 
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used for IFA detection of large T protein in BKV infected HEK cells the 
results were negative. Clone 108 culture fluid was capable of detecting 
SV40 large T protein in SV80 cells. 
Immunoprecipitation from BKV Transformed BHK-21 Cells 
BK-BHK clone L29 TC13 was immunoprecipitated with anti-THE 2 se-
rum and normal hamster serum. The results are shown in Figure 10. At 
passage 13 clone L29 was 0.1% nuclear T protein positive. As can be 
seen in this figure all the proteins precipitated with anti-THE2 serum 
were also precipitated with normal hamster serum. The only difference 
was a slightly more intense series of protein bands in lane B at 22,000 
daltons. The extent of protein precipitated by normal serum indicated 
non-specific precipitation and made interpretation of this gel and 
others like it nearly impossible. This extensive protein precipitation 
with normal serum was a problem unique to the BHK-21 cell type. It was 
not experienced with HEK, SV80 or marmoset infected cells. 
Several changes were made in the protocol to overcome this pro-
blem. The successful changes which were incorporated into the method 
permanently were the use of plastic microfuge tubes for immunoprecipita-
tion and bead washing, and the changing of tubes after each wash. Even 
with these improvements non-specific precipitation from BHK-21 cells re-
mained a recurrent and limiting problem. 
In Figure 11 is an improved immunoprecipitation from clone L29 
TC 16 Faint bands of protein suggestive of the BKV large and small T 
proteins were present in lane A at 94,000 daltons and 22,000 daltons. 




Figure 10. Polyacrylamide gel autoradiograph of immunoprecipita-
tion from BKV transformed, 35s-methionine labeled BK-BHK clone 
L29 TC13 with anti-THE2 serum (lane B) and normal hamster serum 





Figure 11. Polyacrylamide gel autoradiograph of immunoprecipita-
tion from 35s-methionine labeled extract of BK-BHK L29 TC16. Lane 
A precipitated with anti-THE2. Lane B precipitated with normal 






In Figure 12 are the results of immunoprecipitation from clone 
C7 TC14. Faint bands of protein suggestive of BKV large and small T 
proteins can be seen at 94,000 daltons and 22,000 daltons. These bands 
were not precipitated with normal hamster serum. 
DNA Cellulose Chromatography 
In Figure 13 are results of immunoprecipitation from DNA cellu-
lose column eluates. In lane E is an SV80 cell extract precipitated 
with anti-THE2 serum. In lane C is the SV80 cell extract after washing 
at pH 6.0 and elution at pH 9.0. As can be seen the SV40 94,000 dalton 
large T protein eluted at pH 9.0. In lane D is the pH 9o0 eluate preci-
pitated with normal serum. No 94,000 dalton protein was precipitated 
with normal serum. Lanes A and B demonstrate the immunoprecipitation 
pattern from an extract of BKV infected HEK cells for comparison. In 
lane H is the pH 6.0 column eluate precipitated with anti-THE2 serum. 
In lane F is the pH 9.0 column eluate precipitated with anti-THE2 serum. 
As can be seen the 94,000 dalton large T protein was precipitated after 
elution from the column at pH 9.0. Results in lane G demonstrate that 
normal serum did not precipitate the 94,000 dalton protein from the pH 
9.0 column eluate. 
In Figure 14 are the results of immunoprecipitation from DNA 
cellulose column eluates of a BK-BHK C7 TC23 extract. In lane A is the 
C7 TC23 extract precipitated with anti-THE2, demonstrating the presence 
of the 94,000 dalton protein. In lane D is the pH 6.0 column eluate 
precipitated with normal hamster serum. In lane E is the pH 6.0 column 
eluate precipitated with anti-THE 2 serum. A faint band of 94,000 dalton 
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Figure 12. Polyacrylamide gel autoradiograph of immunoprecipita-
tion from 35 s-methionine labeled BKV transformed BHK-21 clone C7 
TC14 extract. Lane A, precipitated with normal serum. Lanes B and 
C, identical samples precipitated with anti-THE2. Electrophore-







Figure 13. Polyacrylamide gel autoradiograph of 35s-methionine 
labeled proteins immunoprecipitated from DNA cellulose column 
fractions. HEK cells were infected with 10 pfu/cell of BKV and 
extracted 10 days later. Lanes A and B, lytically infected HEK 
cell extract precipitated with 2 different lots of anti-THE2 se-
rum for comparison. Lane C, pH 9.0 column eluate of SV80 cell ex-
tract precipitated with anti-THE2 serum. Lane D, pH 9.0 column 
eluate of SV80 cell extract precipitated with normal hamster se-
rum. Lane E, pH 6.0 column eluate of SV80 cell extract precipi-
tated with anti-THE serum. Lane F, pH 9.0 column eluate of BKV 
2 
infected HEK cell extract precipitated with anti-THE2 serum. 
Lane G, pH 9.0 column eluate of BKV infected HEK cell extract pre-
cipitated with normal serum. Lane H, pH 6.0 column eluate of BKV 
infected HEK cell extract precipitated with anti-THE2 serum. E-
lectrophoresis was at 7.5 rnA overnight. 
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Figure 14. Polyacrylamide gel autoradiograph of 35s-methionine la-
beled proteins immunoprecipitated from DNA cellulose column frac-
tions of BK-BHK C7 TC23. Lane A, C7 TC23 precipitated with anti-
THE2 serum. Lane B, pH 9.0 column eluate precipitated with nor-
mal hamster serum. Lane C, pH 9.0 column eluate precipitated with 
anti-THE2• Lane D, pH 6.0 column eluate precipitated with normal 
hamster serum. Lane E, pH 6.0 column eluate precipitated with an-
ti-THE2• Lane F, pH 6.0 column wash number 1 precipitated with an-
ti-THE2. Electrophoresis was at 7 rnA overnight. 
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protein is present. In lane F is the first wash at pH 6.0 precipitated 
with anti-THE 2 serum. No 94,000 dalton protein is present. Results in 
Lane C demonstrate that the 94,000 dalton large T protein is eluted from 
the column at pH 9.0. This protein is not precipitated with normal se-
rum as shown in lane B. 
The Contribution of BKV Small t Protein to Transformation 
The contribution of BKV small t protein to transformation was 
studied with BKV-strain MM (BKV-MM). This strain of BKV cannot make 
small t protein because it is missing an essential sequence for mRNA 
splicing. The two strains can be distinguished by the loss of a Hind III 
restriction site in BKV-MM. This generates 3 BKV-MM Hind III fragments 
instead of 4 and is shown in Figure 15. BKV-MM and the wild type 
(Gardner strain) of BKV were used to transform BHK-21 cells. Two trans-
formants were then immunoprecipitated with anti-THE2 serum. One BHK col-
ony from the control sample was also immunoprecipitated. The results 
are shown in Figure 16. As can be seen from this figure no 22,000 dalton 
small t protein was precipitated from either BKV-MM transformed clone. 
It was precipitated from the BKV-wild type transformed clone. BKV-MM 
transformed cells lacked small t but were capable of virus rescue. 
The transformation frequencies of BKV-wild type and BKV-MM were 
compared. These results are shown in Table 5. In this assay wild type 
BKV transformed BHK-21 cells at an efficiency of 0.90%. BKV-MM trans-
formed BHK-21 cells at an efficiency of 0.91%. BHK-21 control cells not 




Figure 15. Comparison of wild type BKV and BKV-MM DNA. Lane A, 
BKV-MM form I DNA. Lane B, wild type BKV form I DNA. Lane C, BKV-





Figure 16. Polyacrylamide gel autoradiograph of immunoprecipi-
tates comparing wild type BKV transformed BHK-21 cells and BKV-MM 
transformed BHK-21 cells. From left to right BHK-21 cells preci-
pitated with anti-THE 2 serum, wild type BKV transformed cells pre-
cipitated with anti-THE2 serum, BKV-MM transformed BHK-21 clone 5 
precipitated with anti-THE2 serum, BKV-MM transformed BHK-21 clone 
6 precipitated with anti-THE2 serum. Electrophoresis was at 10 rnA 
overnight. 
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TRANSFORMATION FREQUENCY OF WILD TYPE BKV 









a Wild type BKV 
b Transformation frequency was determined as described in Materials and Methods. 
Frequencyb 
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T Antigen Expression After Cell Fusion 
BK-BHK L29 TC20 cells were fused with permissive HEK TCl cells 
using PEG-DMSO. At timed intervals after fusion !FA was done with anti-
THE2 serum. The number of positive cells, both single and multinucleat-
ed, in a total of 1,000 cells were counted at each time. The results are 
shown in Table 6. From an unfused population of L29 TC20 cells only 2 
cells out of 1,000 were positive. A photograph of these cells is shown in 
Figure 17. After fusion the number of postive multi-nucleated cells re-
mained low until the 10 h sample. At this time the number of positive 
multi-nucleated cells increased 38 times. In Figure 18A is a photograph 
of cells 5 h after fusion. Faintly staining nuclei are present in the 
center of the photograph. This faint fluorescence could only be seen in 
photographs. The proportion of positive multinucleated cells remained 
high after 10 h past fusion and reached a peak at 24 h past fusion. In 
Figure 18B and C are photographs of single and multinucleated cells 12 h 
past fusion. The number of positive cells with a single nucleus remain-
ed low until 24 h past fusion when the number increased approximately 10 
fold. This apparent increase may be the result of nuclear fusion. At 
48 h past fusion the distinction between single and multinucleated cells 
could not be made. The proportion of positive cells to negative cells 
decreased at 48 h past fusion as illustrated in Figure 180. 
BK-BHK L29 TC20 cells were fused without the permissive HEK 
cells. The results are shown in Table 7. At 0.5 h past fusion 2 out of 
1,000 cells were positive. Cells 0.5 and 5 h past fusion are shown in 
Figure l9A and B. The number of positive multinucleated cells remained 
low until 10 h past fusion when the number increased 25 times. Cells 10 
Table 6 T ANTIGEN EXPRESSION AFTER CELL FUSION 
BK-BHK-L29TC20-HEKTC3 
Hours Past Fusion Number of Number of Cell Type Counted 







































a Number of cells positive and negative for nuclear tumor antigen as determined by IFA with 
anti-THE2 tumor serum. A total of 1000 cells in random fields were counted. 
b At 0.5 and 48 hours past fusion the distinction between single and multinucleated cells 
























Figure 18. L29 TC20/HEK TC3 fusion. 







Figure 18 (Continued). L29 TC20/HEK TC3 fusion. 
B. IFA with anti- THE 2 serum 12 h past fusion. 
c. I FA with anti-THE2 serum 12 h past fusion. 





Figure 18 (Continued). L29 TC20/HEK TC3 fusion. 




BK-BHK L29TC20-BK-BHK L29TC20 









T ANTIGEN EXPRESSION AFTER CELL FUSION 
Cell Type Counted Number of 















a Number of cells positive and negative for nuclear tumor antigen as determined by !FA 
with anti-THE2 tumor serum. A total of 1000 cells in random fields were counted. 
b At 0.5 h past fusion the distinction between single and multinucleated cells could 




















Figure 19. L29 TC20/L29 TC20 fusion. 
A. IFA with anti-THE2 serum 0.5 h past fusion. 
B. IFA with anti-THE 2 serum 5 h past fusion. 
Initial magnification l60X. 
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and 12 h past fusion are shown in Figure 19C and D. Note the presence 
of positive and negative nuclei in the same multinucleated cell: The 
number of positive multinucleated cells reached a peak at 14 h past fu-
sion and decreased by 24 h past fusion. Cells 14 h and 24 h past fu-
sion are shown in Figure 19E and F. The enlarged nuclei in Figure 19F 
may be the result of nuclear fusion. 
In Table 8 are results of T antigen expression after fusion of 
BHK-21 cells. At all time periods sampled there were no positive cells 
seen. A photograph of fused BHK-21 cells 12 h past fusion is shown in 
Figure 20. Both multinucleated and single cells can be seen in this 
photograph. No positive cells can be seen. 
Factors Influencing the Percentage ofT Positive Nuclei in BKV Trans-
formed BHK-21 Cells: Number of Days in Culture. 
BK-BHK C7 was chosen for the examination of factors influencing 
the percentage ofT positive nuclei in BKV transformed BHK-21 cells. 
Clone C7 TC29 is pictured in Figure 21. The number of days in culture 
past plating and the percentage of nuclear T protein positive cells was 
examined by IFA with anti-THE2 serum. BK-BHK C7 TC28 cells were examin-
ed at 1, 2, 3, and 4 days past plating and a total of 500 cells were 
counted each day. At 1 day past plating the cells could not be counted 
because they detached when fixed. At 2 days past plating 11.6% were 
positive. At 3 days 13.6% were positive and at 4 days 12.0% were posi-
tive. 
Factors Influencing the Percentage of T Positive Nuclei in BKV Trans-
formed BHK-21 Cells: Cell Cycle and the Expression ofT Proteins in 




Figure 19 (Continued). L29 TC20/L29 TC20 fusion. 
C. IFA with anti-THE 2 serum 12 h past fusion. 
D. IFA with anti-THE2 serum 12 h past fusion. 
Initial magnification l60X. 
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Figure 19 (Continued). L29 TC20/L29 TC20 fusion. 
E. IFA with anti-THE2 serum 14 h past fusion. 
F. IFA with anti-THE2 serum 24 h past fusion. 
Initial magnification 160X. 
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Tab 1 e 8 T ANTIGEN EXPRESSION AFTER CELL FUSION 
BHK-BHK 
Cell Type Counted Number of a Single(s) or Multinucleated(m) Ce 11 s Positive 
Hours Past Fusion 
0.5 b 0 
2 s 0 
m 0 
s 0 
m 0 5 
s 0 
m 0 10 
s 0 
m 0 12 
s 0 
m 0 14 
s 0 
m 0 24 
Not fused 0 
a Number of cells positive and negative for nuclear tumor antigen as determined by IFA 
with anti-THE2 tumor serum. A total of 1000 cells in random fields were counted. 
b At 0.5 h past fusion the distinction between single and multinucleated cells could 
not be made. 






















Figure 20. BHK-21/BHK-21 fusion. 
IFA with anti-THE2 serum 12 h past fusion. Initial magnification 
l60X. 
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Figure 21. IFA of BK-BHK C7 TC29 with anti-THE 2 serum. 
Initial magnification 160C. 
l 07 
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The cell cycle was blocked in Gl by serum starvation followed by 
treatement with 1 mM hydroxyurea. The cells were released from· the 
block and at periodic times pulsed with 3H-thymidine. At these same 
times cells were harvested and prepared for IFA as described for the 
cytospin. The results of this experiment are shown in Table 9. There 
was more than a 10 fold increase in counts per minute from 0.5 h after 
release to 5 h after release from the block. The counts per minute then 
decreased to a low at 15 h and peaked again at 18-24 h. This indicates 
a peak in DNA synthesis and a corresponding S phase at 5 h past release 
from the cell cycle block. This is repeated at 18-24 h after release. 
The percent nuclear T protein positive did not show a-corresponding 
change with the onset of S phase at 5 h or with the completion of S 
phase and onset again at 18-24 h. A control sample of unsyncronized 
cells was included with each timed syncronized sample. The control sam-
ples ranged from 25.0-27.5% positive. 
Factors Influencing the Percentage ofT Positive Nuclei in BKV Trans-
formed BHK 21 Cells: Subclone Analysis. 
Subclones of BK-BHK C7 TC23 were isolated by plating single cells 
in microtiter wells. Ten of these were randomly selected for further 
study. The percent of nuclei positive for T protein as determined by 
!FA with anti-THE2 serum in these 10 low passage clones is shown in Ta-
ble 10. These were as follows: Two of the 10 were <0.1% positive, five 
subclones ranged between 0.1% positive to 5.4% positive, one subclone 
was 22.5% positive and two subclones were close to 100% positive. 
C7SC21, 97% positive (Figure 22) and C7SC30, <0.1% positive 
(Figure 23) were examined to determine the relationship between passage 
Tab 1 e 9 CELL CYCLE AND THE EXPRESSION OF TUMOR PROTEINS 
Time after Release Counts Per Percent Nuclear 
From Block (Hours) Minute Tumor Protein Positive 
1/2 1537 '2.'7. 0 
2 11800 24.5 
5 16772 25.5 
8 12442 24.4 
11 7016 27.0 
15 5924 27.0 
24 13033 25.8 
Not synchronized n.d. a 25.0-27.5 b 
aNot done. 
bThe percent nuclear tumor protein positive was determined at each time from an unsynchronized population 




Table 10 SUBCLONE T ANTIGEN REACTIVITY 
a 
b 






















Number of passages in culture past subcloning. 
Percent positive nuclei in 1000 total cells counted. 
Percent Nuclei b 


















Figure 22. IFA of BK-BHK C7SC2l TC24 with anti-THE2 serum. 
A. Initial magnification l60X. 









and the percent of cells positive for nuclear T protein. The results 
are shown in Table 11. C7SC21 remained close to 100% positive through 
27 passages. C7SC30 did not remain <0.1% positive. After 14 passages 
0.2% of the cells were positive. 
Results of immunoprecipitation from C7SC21 TC12 and C7SC30 TC13 
are shown in Figure 24. In lanes A and B are C7SC30 and C7SC21 extracts 
immunoprecipitated with anti-THE2 serum. Before the addition of Protein 
A-Sepharose beads these extracts were first incubated with an unlabeled 
BHK-21 cell extract. Small t protein bands are present in both lanes at 
22,000 daltons. Protein bands suggestive of large T protein are present 
at 94,000 daltons. In lane Dis immunoprecipitation from a BHK-21 cell 
extract. No bands migrating in the range of small t can be seen. Faint 
bands of protein can1 be seen where the 1 a rge T protein would migrate. 
In lanes E and Fare immunoprecipitates from lysates of C7SC30 TC13 and 
C7SC21 TC12. These lysates were not pre-incubated with an unlabeled 
BHK-21 cell extract. The protein precipitation patterns were very simi-
lar whether or not an unlabeled BHK-21 cell extract was pre-incubated 
with the labeled extracts. The amounts of 94,000 dalton large T protein 
in C7SC21 TCll and C7SC30 TC13 were compared by three successive immuno-
precipitations from each lysate. By this method a difference between 
the amounts of large T protein in C7SC21 and C7SC30 could not be detect-
ed (data not shown). When extracted cells from subclones C7SC21 and C7 
SC30 were subjected to IFA with anti-THE2 serum fluorescence was still 
present. 
The plating efficiency and virus rescue titer were compared for 
C7SC2l and C7SC30. The results are shown in Table 12. The plating ef-
Table 11 SUBCLONE CONTINUAL PASSAGE DETECTION OF TUMOR PROTEINS 
BK-BHK Clone Passage Number Percent Positivea 








a Tumor proteins were detected by IFA with anti-THE2 tumor serum. The percent positive reflects the 




Figure 24. Polyacrylamide gel autoradiograph of 35s-methionine 
labeled immunoprecipitated proteins from C7SC21 TC12 and C7SC30 
TC13 precipitated with anti-THE2 serum. Lane A, C7SC30 TC13 pre-
cipitated with anti-THE2 serum. Lane B, C7SC21 TC12 precipitated 
with anti-THE2 serum. Lane D, BHK-21 cell extract precipitated 
with anti-THE2 serum (lane C 1/10 the sample volume of lane D). 
Lane E, C7 SC30 TC15 precipitated with anti-THE2 serum. Lane F, 
C7SC21 TCll precipitated with anti-THE2 serum. The 1.0 ml lysates 
generating the results in lanes A and B were incubated with 2.3 ml 
unlabeled BHK-21 cell extracts plus 20 wl anti-THE2 serum for 30 
min before the addition of Protein A-Sepharose beads. Electrophor-
esis was at 12.5 rnA overnight. 
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Table 12 
Plating Efficiency in 
0.33% Agara 
Virus Rescue Titer 
from HEK/BK-BHK Fusiona 
BK-BHK C7SC3D AND BK-BHK C7SC21 PLATING 
EFFICIENCY AND VIRUS RESCUE 





aPlating efficiency and virus rescue titer were determined as described in Materials and Methods. 
1 ?0 
ficiencies for C7SC21 and C7SC30 were 7.3% and 8.0% respectively. The 
virus rescue titers for C7SC30 and C7SC21 were also compared. The res-
cue titers for C7SC30 and C7SC21 were also compared. The rescue titer 
2 2 for C7SC30 was 5o3 X 10 /ml and that for C7SC21 was 5.7 X 10 /ml. For 
these two subclones both the plating efficiencies and the virus rescue 
titers were very similar. 
Growth curves of BHK-21 cells, the parental C7TC25 and the two 
subclones C7SC21 and C7SC30 were compared in DME plus 10% CS and 10% TPB. 
The results are shown in Figure 25. As can be seen from this figure 
C7SC21, 98% T positive did not increase in cell number more rapidly than 
C7SC30, 0.2% positive. In Figure 26 are growth curves of the same cells 
in DME plus 1% CS, 1% TPB. The untransformed BHK-21 cells did not in-
crease in cell number under these low serum conditions. All 3 trans-
formed clones did increase in cell number in these conditions. In 1.0% 
serum as in 10% serum C7SC21 did not exhibit a more rapid increase in 
cell number from 1-3 days past plating. The parental C7TC25 clone was 





Figure 25. Growth curve comparing growth rates of BHK-21, C7TC25, 
C7SC30 TC14, and C7SC21 TC13 in DME plus 10% CS, 10% TPB. BHK-21 
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Figure 26. Growth curve comparing growth rates of BHK-21, C7TC25, 
C7SC30 TC14 and C7SC21 TC13 .in DME plus 1% CS, 1% TPB. 
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CHAPTER V 
DISCUSSION 
This study examined the transformation of BHK-21 cells to an-
chorage independence by BKV. It follows an observation made in this 
laboratory that a clone (L29) of BKV transformed BHK-21 cells appeared 
nuclear T antigen negative by IFA and immunoperoxidase assays yet was 
capable of virus rescue (80). This observation stimulated many ques-
tions as considerable evidence indicated that the SV40 large T protein 
was necessary for viral DNA replication, and transformation initiation 
and maintenance. The current study was undertaken to examine the L29 
clone and other clones of anchorage independent BKV transformed BHK-21 
cells first for the presence of the BKV large and/or small T proteins, 
then for the parameters which may influence or be influenced by the ex-
pression of these viral proteins. 
The antiserum used in these studies was made in hamsters to an 
SV40 transformed cell line, THE 2. For the study of cells transformed 
by BKV the use of an antiserum directed to BKV transformed cells would 
have been preferable. However, as shown in Table 4 two attempts were 
made to produce antisera with RF194 cells. Both times antiserum was 
produced which was capable of immunoprecipitating from BKV infected HEK 
cells a 94,000 dalton protein likely to be large T but incapable of pre-
cipitating a protein with a molecular weight consistent with a small t 
protein. This is illustrated in Figure 6. Although the small t pro-
tein was present in RF194 cells as detected by immunoprecipitation and 
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SDS polyacrylamide gel electrophoresis (data not shown) the protein could 
not stimulate antibody in hamsters capable of immunoprecipitating the 
protein from cell extracts. There are several possibilities which might 
account for this. One is that antibody may actually be generated by 
RF194 cells but be incapable of reacting by immunoprecipitation. Another 
is that small t protein determinants may be sequestered and therefore 
unable to elicit an antibory response. One more possibility is that once 
small t is extracted from cells it may no longer be in a conformation 
recognizable by the antibody. 
When anti-THE2 serum was used to immunoprecipitate from BKV in-
fected HEK cells prominent bands migrating at 94,000 daltons and 22,000 
daltons in SDS polyacrylamide gels were precipitated with anti-THE2 serum 
and not normal serum. This is shown in Figure 7. They were also not 
precipitated from uninfected cells (data not shown). In addition, pro-
tein bands at 94,000 daltons and 22,000 daltons were precipitated from 
BKV infected marmoset brain cells with anti-THE 2 serum and not normal 
serum. An additional 18,000 dalton band was precipitated. The nature 
of these two bands migrating in the region of small t is not known. The 
smaller protein may be a proteolytic product of the 22,000 dalton protein 
or the result of integration which allows only a truncated form of small 
to to be made. 
These results established that the anti-THE 2 serum was a reagent 
capable of specifically precipitating proteins migrating at 94,000 daltons 
and 22,000 daltons from 2 different lytically infected cell types. A-
long with the characteristic molecular weights in 2 cell types there is sub-
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stantial evidence presented throughout this work which further identi-
fies these proteins. Summarized here, this includes the co-migration of 
these proteins in SDS polyacrylamide gels with SV40 large and small T 
proteins from SV80 cells. It includes the characteristic DNA-cellulose 
binding capability of the 94,000 dalton protein at pH 6.0 and elution 
above pH 8.0. This also includes the lack of an anti-THE 2 precipitated 
22,000 dalton protein from BHK-21 cells transformed by BKV-MM. 
After the establishment of the apparent molecular weight of BKV 
large and small T proteins in this 50S-polyacrylamide gel system BK-BHK 
clone L29 was examined for T proteins by immunoprecipitation with anti-
THE2 serum. Many results of immunoprecipitation from BHK-21 cells were 
uninterpretable because of non-specific precipitation. The autoradio-
graph in Figure 10 of immunoprecipitation from clone L29 is an example 
of this. When immunoprecipitating from BK transformed hamster cells 
with an antiserum made in hamsters against hamster cells the presence of 
many non-viral proteins in a precipitate would be expected. The 
presence of many proteins precipitated by normal hamster serum in Figure 
10 however, indicates non-specific precipitation. This is a problem 
specific to BHK-21 cells and has been reported by others. Hutchinson 
et al. (53) studied polyoma viral proteins in transformed BHK-21 cells. 
After immunoprecipitating from these cells with normal serum and anti-
tumor serum followed by SDS polyacrylamide gel electrophoresis and auto-
radiography they found sections of their gels uninterpretable because of 
extensive precipitation with normal serum. The problem of non-specific 
immunoprecipitation from transformed BHK-21 cells has also been exper-
ienced with the use of monoclonal antibody directed to viral protein 
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instead of anti-tumor serum (K. Rundell personal communication). Al-
though the non-specific precipitation remained a recurrent probl~m 
throughout this work some minor changes in the immunoprecipitation meth-
od yielded auroradiographs with interpretable results. 
In Figure 11 is an autoradiograph of SDS polyacrylamide gel e-
lectrophoresis of immunoprecipitates from BK-BHK L29 TC16. This is a 
passage where <0.1% of the cells appear nuclear T positive by IFA with 
anti-THE2. In this figure bands of protein are present at 94,000 dal-
tons and 22,000 daltons precipitated by anti-THE2 and not normal serum. 
This suggests that even though this L29 clone is <b.l% nuclear T posi-
tive by IFA that small amounts of large T and small t proteins are pro-
duced. This may reflect low levels of synthesis in all or most cells or 
it may reflect high levels of synthesis in rare cells. 
The continual synthesis of BKV large T protein in all cells of 
transformed BHK-21 clones should not be a requirement for continued 
growth in culture. Prior to the transformation event BHK-21 cells al-
ready exhibit some characteristics of papovavirus transformed cells. 
They have an infinite lifespan, they do not contact inhibit well and on 
rare occasions have been reported to form tumors in hamsters. BKV trans-
formed BHK-21 cells however can be selected by anchorage independent 
growth. When replated in soft agar suspension they exhibit increased 
plating efficiency over the untransformed BHK-21 cells as shown in 
Table 2. It is possible that the transformation initiation event itself 
and growth in suspension require uniform T/t synthesis but that routine 
growth in tissue culture media does not. 
The contribution of BKV small t protein to transformation and 
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anchorage independent selection was studied with BKV-MM. This mu-
tant carries a deletion which prevents the formation of small t mRNA. 
Thus, small t protein is not made in cells transformed with this virus 
as shown in Figure 16. When BKV-MM and wild type BKV were used to 
transform BHK-21 cells it was determined that they transformed these 
cells with similar efficiencies (Table 5). These results are in agree-
ment with studies with SV40 small t mutants. These studies found that 
the lack of small t may or may not influence the transformation effi-
ciency depending on the cell type, the growth state of the cell and 
the method of selection. In a study by Frisque et al. (34) they examin-
ed two cell types, rat embryo fibroblasts (REF) and hamster embryo fibro-
blasts (HEF). They found that early passage, rapidly growing REF cells 
transformed by the .54-.59 small t deletion mutant grew in suspension 
with the same efficiency as wild type virus. When senescent REF cells 
were used however, the efficiency of growth in suspension for the .54-
.59 mutant was significantly less than wild type SV40. When HEF cells 
transformed by the .54-.59 mutant were examined growth in suspension was 
not influenced. For both REF and HEF cells transformed with tsA mutants 
cloning efficiency in suspension was considerably less at the restrictive 
temperature indicating a dependence on large T for growth in suspension. 
In the current study rapidly growing BHK-21 cells were harvested 
and used for the transformation. The transformation efficiency and 
growth in agar suspension was not affected by the lack of small t pro-
tein. Since there is no BKV large T mutant available the contribution 
of large T can only be inferred by comparison with SV40. A further study 
should include a comparison of transformation frequencies of BKV-MM in 
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rapidly growing and non-dividing BHK-21 cells. A non-dividing popula-
tion of BHK-21 cells could be obtained by utilizing BHK-21 cells plated 
in 1% CS (see Figure 26). 
Although the BKV large T protein should not be essential for 
continued growth of BKV transformed BHK-21 cells in routine culture, if 
evidence accumulated for SV40 can be applied to BKV then the large T 
protein should be necessary for virus rescue. Virus rescue upon fusion 
with permissive cells is a very inefficient process. Among approximately 
3 X 106 cells exposed to PEG-DMSO the virus rescue titer for L29 cells 
is 5 X 103 virions in a total of 5.0 ml of lysate. Theoretically, if a 
virus producing heterokaryon produces 100 virions then one cell in every 
6 X 103 could be responsible for the virus rescue. The rare T positive 
cell seen in clone L29 in early passages (before TC20) could be the cell 
responsible for virus rescue upon fusion. Alternatively, since large T 
is necessary but not sufficient for viral DNA replication the fusion 
process may greatly enhance the production of T protein independent of 
virus production. To examine this possibility BK-BHK L29 cells were 
fused with permissive HEK cells and at intervals after fusion cells were 
examined for the production of nuclear T protein. T protein was det~ct­
ed by IFA with anti-THE2 serum. After fusion there was an increase in 
the proportion ofT positive cells which peaked at 24 hours past fusion. 
Most T positive cells were multinucleated. However, at 24 h past fusion 
there was an apparent increase in positive cells with single nuclei. 
Nuclear fusion is probably responsible for this increase. By 48 h past 
fusion the negative single cells overgrow the positive cells, decreasing 
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the relative number of positive to negative cells. This is illustrated 
in Figure 180. 
Further results shown in Table 7 indicated that fusion with per-
missive cells was at least not the only factor responsible for the in-
crease in T positive polynucleated cells seen after fusion. Fusion with 
the permissive cell type is however, necessary for infectious virus pro-
duction. When L29 cells were fused without permissive cells an increase 
in the relative number of positive cells was seen. This began at 10 h 
past fusion. Figure 19 demonstrates that in a polynucleated cell there 
can be both positive and negative nuclei. This increase in T positive 
cells after fusion is a finding not shared with the un-transformed paren-
tal BHK-21 cells as shown in Table 8. 
Although the permissive cells may contribute to the increase in 
T positive cells upon fusion with transformed cells they are certainly 
not the only factor. The fusion process itself is also responsible for 
inducing the production or the increased production of virally induced 
or virally coded for protein reactive with the anti-THE2 serum. Since 
the antiserum used was raised against transformed cells there is a pos-
sibility that the increased reactivity after fusion is due to a cellular 
and not a viral protein. To resolve this question 4 clones of hybridoma 
cells secreting antibody to SV40 large T protein were obtained. Mono-
clonal antibodies to BKV T proteins have not been made. It was unex-
pected and unfortunate that these antibodies did not cross-react with 
BKV large T protein. However, even if the monoclonal antibody had 
cross reacted there is a possibility that the particular specificity 
may not react with the subclass of BKV T which may be produced after 
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fusion. 
It is not clear what factors are responsible for the results ob-
tained when the L29 clone is exposed to DMSO. It is possible that upon 
fusion certain factors which allow the expression of previously silent 
genes are transferred from one cell to another. Perhaps the mRNA for T 
protein can be transcribed in one cell but not translated and can be 
translated in the second cell but not transcribed. The defects would 
compliment each other upon fusion. The finding of both positive and 
negative nuclei in the same polynucleated cell would support this hypo-
thesis (see Figure 19). 
It is also possible that D~1SO treatment may be activating pre-
viously silent gene expression. It has been reported that DMSO is ca-
pable of inducing cellular differentiation (50,126). When cultured 
Friend leukemia cells are treated with 2% DMSO they begin to accumulate 
globin specific mRNA and synthesize hemoglobin (50). Since DMSO is ca-
pable of changing transcriptional activity in cells it is feasible that 
it could activate silent viral genes in BKV transformed BHK-21 cells. 
Experiments studying the separate and collective effects of PEG and 
DMSO on transcriptional and translational activity in BKV transformed 
BHK-21 cells should follow. 
In Figures 1-5 are examples of detection ofT protein by IFA with 
anti-THE2 serum. The striking difference between the SV40 transformed 
human cells in Figure 1 and the BKV transformed BHK-21 cells in Figures 
2-5 is that the SV80 cells are uniformly positive and the BKV trans-
formed BHK-21 cells are not. Mouse, rabbit, and monkey cells transform-
ed by BKV were approximately 100% positive for T protein as reported by 
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Portolani et al. (87). In some clones (Figures 2 and 3) rather than 
clearly positive and negative nuclei what exists are positive and neg-
ative nuclei and varying levels of reactivity in between. In other 
clones cells are clearly positive or negative (Figure 21). 
The percentage ofT antigen positive nuclei increased with the 
cell passage as shown in Table 3. Because of the stimulatory effect of 
T protein on DNA synthesis the rare positive cells seen at early pas-
sages may have a slight growth advantage over the negative cells. The 
percentage of positive cells would therefore increase with passage. A-
nother explanation for the increased percentage of T protein positive 
cells with passage involves the inherent heterogeneity of BHK-21 cells. 
Ehlke (29) studied the karyotype of BHK-21 cells used in this laboratory 
and found the chromosome number and arrangement to be highly variable. 
An early study by Fraser et al. (33) followed the accumulation of poly-
oma virion antigen synthesis in BHK-21 cells by IFA. Their results sug-
gested that cellular heterogeneity, perhaps due to spontaneous mutation, 
was responsible for the semi-permissiveness of BHK-21 cells. 
Folk et al. (32) repeated similar experiments with the use of a polyoma 
DNA probe and in situ hybridization. When 40 pfu/cell of polyoma virus 
was used to infect BHK-21 cells isolated foci of DNA replication were 
observed. This indicated that the semi-permissiveness of BHK-21 cells 
for polyoma virus replication is due to cellular heterogeneity. Pre-
vious studies had shown that viruses that replicate in BHK-21 cells do 
not have detectable genomic alterations (145). In the current study 
changes in chromosome arrangement and number with increasing genera-
tions past the original single cell progenitor may activate silent 
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genes. Karyotype studies comparing early passage transformants with 
late passage transformants should be done to examine chromosomal-differ-
ences. 
In one clone (C4) the increase in T positive cells was not grad-
ual. At passage 15 it increased 10 fold and decreased 10 fold by pas-
sage 16. It is not clear what may have caused this. One factor which 
was not controlled for was the effect of storage in liquid nitrogen and 
then thawing, growing and assaying the cells. Although every effort was 
made to assay cells at the same state of semi-confluency occasionally 
there were slight variations in the time of sampling. The T protein syn-
thesis may respond to certain levels of growth hormones present in the 
growth media at different times. Clone C7 however, was assayed 2, 3, and 
4 days past plating and the number of days in culture for this clone had 
no effect on the percentage ofT positive cells in the culture. 
Factors which could possibly influence the expression ofT pro-
tein were further examined with Clone C7. Since the expression ofT pro-
tein and transport into the nucleus could be cell cycle dependent syn-
chornized populations of cells from clone C7TC29 were examined for T 
protein. Considering the role of SV40 T protein in the stimulation of 
cellular DNA synthesis it is possible that T protein might accumulate in 
the nuclei of a large percentage of cells during S phase. Results pre-
sented here however, did not indicate this. This suggets that BKV large 
T protein may not be involved in the stimulation of BHK-21 cellular 
DNA synthesis of BKV-transformed cells under the conditions of this ex-
periment. 
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Another factor which may influence the expression ofT protein is 
the heterogeneity of BHK-21 cells. Subclones of C7TC23 were isolated 
to determine if the expression of T protein in clone C7 is clonal in ori-
gin. In other words, could completely positive or negative subclones be 
isolated. Previous evidence indicated that there is some clonal influ-
ence. This evidence consists of the fact that often clusters of positive 
cells would be seen in assays forT protein by IFA with anti-THE 2 serum 
(see Figure 2). Single positive cells however, could also be seen (Fig-
ure 21). Out of 10 randomly chosen subclones 2 were almost totally posi-
tive, 2 were almost totally negative and 6 were mixtures of positive and 
negative cells similar to the parental line. These results, especially 
the isolation of positive or negative subclones indicate clonal influ-
ence in the expression ofT protein in BKV transformed BHK-21 cells. The 
6 subclones containing mixtures of positive and negative cells may have 
been exclusively positive or negative early in the subcloning and changed 
by the time sufficient numbers of cells were present to assay. 
Two subclones, one negative (SC30) and one positive (SC21) were 
chosen for further study. When they were subjected to continual passage 
SC30 became increasingly positive and SC21 remained >96% positive. The 
isolation of a line of BKV transformed BHK-21 cells almost completely T 
protein positive is unique and indicates the isolation of an unusually 
stable population of cells. The isolation of a subclone which is <0.1% 
T positive and which becomes increasingly positive with passage supports 
the theory that in most cases the heterogeneity of BHK-21 cells is relat-
ed to or responsible for the expression ofT proteins. 
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The isolation of subclones which were either >97% T positive or 
<0.1% T positive provided useful tools for studying the effect of nuclear 
T protein, as detected by IFA with anti-THE2, on the phenotype of these 
transformed cells. The fact that both subclones are capable of similar 
virus rescue titers is not surprising. Results presented here with clone 
L29 indicate that the fusion process itself is capable of inducing the 
production ofT proteino In addition, while T protein is necessary for 
virus DNA replication it is not sufficient. 
There are several possible explanations for why the percent of T 
positive cells did not influence the cloning efficiency in suspension or 
the growth rate in 10% and 1% serum. One possibility that cannot be over-
looked although unlikely, is that the protein(s) responsible for the reac-
tivity in C7SC21 could be viral induced cellular protein(s) reactive with 
anti-THE2 serum. Immunoprecipitation from both subclones could not demon-
strate an increased amount of large T protein or any precipitable protein 
in C7SC21. However, after IFA of NP-40 extracted monolayers of SV80 and 
C7SC21 cells fluorescence remained, indicating that protein(s) reactive 
with anti-THE2 serum were still present. Therefore, under these extrac-
tion conditions IFA and immunoprecipitation results could not be compared 
on a quantitative basis, and immunoprecipitation could not confirm the 
viral origin of the protein(s) responsible for the IFA results. Had the 
monoclonal antibodies to SV40 cross-reacted with BKV T proteins a defini-
tive answer may have been obtained. A more likely explanation for the 
subclone plating efficiency and growth curve results is that the low lev-
els ofT protein present in C7SC30 cells may be sufficient to account for 
the plating efficiency in suspension and the growth rate in 10% andes-
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pecially 1% serum. The fact that BHK-21 cells already exhibit some as-
pects of transformed cells may be related to these results. 
In conclusion results have been presented which demonstrate the 
presence of BKV large 94,000 dalton T protein and small 22,000 dalton t 
protein in cells lytically infected and transformed by this virus. The 
large T protein from both lytically infected and transformed cells is 
capable of characteristic binding to a column of DNA cellulose. 
The factors which control the unique pattern of large T protein 
expression in these BKV transformed BHK-21 cells were examined. Results 
suggested that rather than a cyclic turning on and off of nuclear large 
T protein expression a clonal influence possibly related to the inherent 
heterogeneity of BHK-21 cells was responsible. 
Results indicated the transformation efficiency and subsequent 
growth in suspension to be independent of small t protein for these BKV 
transformed BHK-21 cells. Perhaps the state of growth is as important in 
BKV transformation of BHK-21 cells as in transformation by SV40. 
This work has generated several interesting questions yet to be 
answered. One is the elucidation of the molecular basis for the expres-
sion of T protein after exposure to PEG-DMSO; whether this expression is 
the result of DMSO treatement or fusion with other transformed cells. 
Another is the examination of chromosomal differences between early pas-
sage and late passage transformants and how these differences might re-
late to the increased proportion ofT positive cells in later passage 
clones. Thirdly, the effect of the BKV-MM mutation on the transformation 
of a non-dividing population of BHK-21 cells as compared to a dividing 
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population has yet to be determined. 
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